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ABSTRACT

Selenium and Iron in the Rat Intestine: Effects on Lipid Peroxidation
by
Sileny Vega, Doctor of Philosophy
Utah State University, 1989

Major Professor: Dr. A. Mahoney
Department: Toxicology

Effects of Fe and Se status on GSHPx activity and lipid peroxidation in liver and
intestinal mucosa were studied. Rats were Se and Fe supplemented (+Se+Fe), Sedeficient and Fe-supplemented (-Se+Fe), Se supplemented and Fe overloaded (+Se++Fe)
by intramuscular injection, or Se deficient and Fe overloaded (-Se++Fe) for 20d.

Fe

overloaded tissues had more Fe, but hemoglobin was unaffected. Liver and mucosal
GSHPx activity was low in Se-deficient rats. Thiobarbituric acid reactive substances
(TBARS) were higher in Fe overloaded and -Se++Fe vs +Se++Fe tissues. Mucosal
TBARS was higher in -Se++Fe rats gavaged with CBrCl3. In experiment 2, Fe overload
was induced by a 2% carbonyl iron, low-Se diet fed for 2mo, the +Se++Fe and -Se++Fe
groups. Low Se-, low Fe-diet was fed to rats supplemented with Fe or Fe and Se in the
water, the -Se+Fe and +Se+Fe controls. Iron overloaded tissues had more Fe. Liver and
mucosal GSHPx activity was lower in Se-deficient and +Se++Fe vs +Se+Fe rats.
TBARS was higher in Fe overloaded, -Se++Fe vs +Se++Fe, and CBrCl3 tissues.
Hemoglobin and serum Fe were lower in the -Se++Fe group. In experiment 3, low-Se,
low-Fe diet was fed for 20d, the -Se-Fe, +Se-Fe, -Se+Fe and +Se+Fe groups. Mucosal
Fe w s 1 wer i the Fe-deficient rats. Cytochrome P-450 and GSHPx activities were

ix

lower and TBARS was higher in Se-deficient tissues. In experiment 4, the +Se+Fe, +SeFe, -Se+Fe, -Se-Fe, +Se++Fe, and -Se++Fe groups treated as in experiment 3. Iron
overloaded tissues had more Fe and TBARS, but hemoglobin and serum Fe were
unaffected. GSHPx and Cytochrome P-450 activities were lower in Se-deficient and in
+Se++Fe vs +Se+Fe rats. CBrCl3 did not affect TBARS.
High TBARS occurred in liver and mucosa of Fe overloaded rats. Chronic Fe
overload was required to reduce liver and mucosal GSHPx activity. The combination of
Se deficiency and Fe overload caused very high TBARS. Low oral CBrCl3 doses
elevated mucosal TBARS, a first report of extrahepatic action of CBrCl3 in vivo. Iron
deficiency did not affect GSHPx activity or CBrCl3 induced lipid peroxidation.
(100 pages)

CHAPTER I
INTRODUCTION

Lipid peroxidation has been growing in medical importance. Several diseases and
toxic cell injuries have been associated with free-radical disturbances. These diseases
include inflammation, rheumatoid arthritis, atherosclerosis, alcoholism, Fe overload of the
liver, toxic liver injury (such as that related to bromotrichloromethane), tumor promotion,
some examples of chemical carcinogenesis, reperfusion injury, and cirrhosis (Slater,
1987).
Nutritional disorders associated with free-radical disturbances can be due to a
deficient intake of a required nutrient such as vitamin E or selenium (Se), a constituent of
the enzyme glutathione peroxidase (GSHPx); both have protective antioxidant effects. A
deficient intake of Fe can increase the amount of unsaturated lipids in the cellular
membrane (Larkin et al., 1986) and can also induce fatty livers (Bartholmey and
Sherman, 1985), conditions that favor lipid peroxidation of the cell in different organs and
in liver. Iron deficiency can also lower the enzymatic activity of GSHPx and catalase
(Rodvien et al., 1974; MacDougall, 1972), both important lines of cellular defense against
lipid peroxidation. Nutritional disorders can also be due to excess intake of substances,
such as transitional metals like iron (Fe), that can stimulate free-radical production. Iron
overload can also lower the hepatic Se-dependent GSHPx activity (Reffet et al., 1986; Lee
et al., 1981).
Selenium deficiency and, more recently, high Fe stores have been related to an
increased incidence of cancers. Epidemiological evidence shows an inverse relationship
between Se intake and certain forms of cancer in humans, especially intestinal and breast
cancers. Some studies also show an inverse association between cancer incidence and Se
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concentration in local forage plants and in human blood. It is possible that Se deficiency
does not cause cancer but increases susceptibility to cancer development (Jacobs, 1977;
Schrauzer, 1976; Knekt et al., 1988).
Several studies support the hypothesis that high body Fe stores increase the risk of
cancer in humans (Selby and Friedman, 1988).

It

~as

found that hepatocellular

carcinoma is one of the two leading causes of death in patients with hereditary
hemochromatosis (Britton et al., 1987).

Hemochromatosis is a disorder of Fe

metabolism in which massive amounts of Fe are deposited in various organs. Full
expression of the disease occurs in homozygotes, and body Fe stores are abnormal in a
significant portion of heterozygotes (Edwards et al., 1982). It is estimated that about one
in ten individuals are heterozygous for the disease (Skikne and Cook, 1987).
Lipid peroxidation is a free-radical-mediated process that can result in acute
cellular injury, especially if the normal protective mechanisms of the cell are reduced. On
the other hand, lipid peroxidation itself and some of its by-products are potential initiators
and promoters of cancer (Vaca et al., 1988; Weinstein, 1981).
Experimental evidence suggests that Fe is involved in the initiation of lipid
peroxidation. It is generally accepted that Fe may serve as a catalyst for the formation of
the hydroxyl radical (·OH), which initiates lipid peroxidation (Minotti and Aust, 1987).
Glutathione peroxidase is an important line of cellular defense against lipid
peroxidation (Rotruck et al., 1973; Flohe et al., 1973). It has central importance in
protecting against the pro-oxidative consequences of metabolic activation of oxygen
(generation of ·OH) via the reduction of H202 in the cell. It also catalyzes the reduction of
organic hydroperoxides formed from unsaturated fatty acids, blocking the subsequent freeradical formation (Mills, 1957; Little and O'Brien, 1968).

However, no direct

relationship between lowered Se-dependent GSHPx protection against lipid peroxidation
an cancer initiation or promotion has been established.
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In several tissues including liver, a percentage of the total GSHPx is Seindependent and can be induced during Se deficiency; in contrast, no Se-independent
GSHPx is found in the rat intestine (Levander, 1982). Due to the fast cell turnover rate of
this tissue and to its dependence on Se from the diet and not from body stores of the
element (Pascoe et al., 1983), the intestinal GSHPx protection against free-radicals
damage could be seriously compromised by an Se-deficient diet. The fast turnover rate of
cells in the intestinal tract also makes this epithelium particularly susceptible to the action
of free radicals. This is probably true also for mutagens and carcinogens, which can
originate from the diet and exert their toxicity through the generation of oxygen radicals
(Ames, 1983). The role of Fe in mediating free-radical damage to gastric mucosal cells
has been documented (Hiraishi et al., 1988); it is also known that Fe deprivation might
affect most severely those tissues that have a rapid growth and rate of cell division or
tissues with high metabolic rates (Pascoe et al., 1983).
In the present study, the in vivo effect of Se deficiency (bdependently and also in
combination with Fe overload or with Fe deficiency) on the livers and intestines of rats
was investigated. Four parameters were evaluated: 1) liver cytochrome P-450 activity, 2)
hepatic and intestinal Se-dependent GSHPx activity, 3) hepatic and intestinal lipid
peroxidation, and 4) total Fe at the liver and at the intestine,
Theoretically, these parameters have the potential to influence, individually and in
combined modes, the development of intestinal and hepatic cancer. They could also
influence other diseases associated with free-radical disturbances.
Two models of experimental Fe overload induction were used: oral ingestion of
carbonyl iron, which induces hepatic Fe distribution in a pattern analogous to that seen in
human hereditary hemochromatosis (in hepatocytes), and intramuscular injections of iron
dextran, which induce a more homogeneous deposition (in hepatocytes and Kupffer cells)
(Bacon et al., 1986). Both forms of Fe are used in therapy for Fe-deficiency anemia.
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CHAPTER IT
LITERATURE REVIEW
IRON OVERLOAD

Hemochromatosis
Iron overload is a medical problem in a number of disorders commonly called
hemochromatosis. Hereditary hemochromatosis was once considered to be a rare disease;
we know now that it is one of the most common autosomal recessive disorders. It is
estimated that about one in ten individuals in northern Europe, North America, and
Australia are heterozygous and that 2-3/10,000 people are homozygous (Skikne and
Cook, 1987). Full expression of the disease occurs in homozygotes, and measurements
of body-Fe stores are abnormal in a significant portion of heterozygotes (Edwards et al.,
1982).
Iron overload can result from increased absorption of dietary Fe, by parental
administration, or both. Although it is clear that certain cases of hemochromatosis are
secondary to transfusional Fe loading or to a huge dietary excess of Fe, in most cases, the
disease has been termed idiopathic in origin.
Iron balance is regulated by controlling Fe absorption. The absorption of Fe is
reciprocally related to body-Fe stores, so that as stores decline absorption increases and
vice versa. The biochemical signals influencing rates of Fe absorption and the ultimate
mechanisms by which the epithelial cells of the intestine absorb Fe are not known. A
defect in this homeostatic control mechanism seems to be the cause of Fe overload in
hereditary hemochromatosis (Britton et al., 1987).
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Hemochromatosis is a disorder of Fe metabolism characterized clinically by
hepatic cirrhosis, skin pigmentation, arthropathy, cardiomyopathy, and endocrinopathies.
Most of these clinical findings are the result of organ damage due to the deposition of
massive amounts of Fe (Edwards et al., 1982).
Two models of experimental Fe overload induction in rats are generally used:
intramuscular injections of iron dextran and oral ingestion of dietary carbonyl iron (Dillard
et al., 1984; Bacon et al., 1986). Carbonyl iron induces Fe distribution in a pattern
analogous to that seen in human hereditary hemochromatosis (in hepatocytes), while a
more homogeneous deposition (in hepatocytes and Kupffer cells) has been observed with
parenteral Fe (Bacon et al., 1986).
Cancer
Several studies support the hypothesis that high body-Fe stores increase the risk
of cancer in humans (Selby and Friedman, 1988) and the increase of overall death rates
(Stevens et al., 1983).
It was found that complications of chronic liver disease and hepatocellular
carcinoma were the two leading causes of death in patients with hereditary
hemochromatosis. It appears likely that cirrhosis is a prerequisite for the development of
hepatic cancer in these patients since all liver cancers developed in cirrhotic livers, and
there are no reports of liver cancer developing in noncirrhotic patients with
hemochromatosis (Britton et al., 1987).
Two lines of evidence provide a biologic rationale for the hypothesis. First, Fe
can catalyze the production of oxygen radicals, and these may be proximate carcinogens.
Second, Fe may be a limiting nutrient for the growth and development of cancer cells;
excess Fe may increase the chances that cancer cells will survive and flourish (Stevens et
al., 1988).
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Lipid peroxidation
A plethora of evidence from in vivo and in vitro studies suggests that Fe is
involved in the initiation of lipid peroxidation and may be responsible for the observed
tissue damage associated with various Fe overload related pathologies (Britton et al.,
1987).
Mechanisms of action
Most of our understanding of the pathophysiological effects of excess tissue Fe is
derived from clinical and/or experimental studies of the effects of Fe on the liver. In
hereditary hemochromatosis, the liver is the major recipient of the excess absorbed Fe.
Despite the existent convincing clinical evidence for the hepatotoxicity of excess Fe, the
specific pathophysiological mechanisms for hepatocyte injury and hepatic fibrosis in
chronic Fe overload are poorly understood (Britton et al., 1987).
Several mechanisms whereby excess hepatic Fe causes cellular injury with
resultant fibrosis and cirrhosis have been proposed. The biochemical form of intracellular
Fe responsible for initiating these hepatotoxic manifestations is unknown. In conditions
of Fe overload, the ability of the hepatocyte to maintain Fe in the nontoxic protein-bound
ferric state may be exceeded, resulting either in small amounts of ferrous Fe or in
excessive amounts of of low molecular weight chelate Fe in the cytosol (Britton et al.,
1987). Iron in these forms in the presence of available cellular reductants (ascorbate,
NADPH) may play a catalytic role in the initiation of peroxidative injury to
polyunsaturated fatty acids of membrane phospholipids of organelles. This results in
abnormalities of organelle functions, which are dependent on intact organelle membrane
structure (Minotty and Aust, 1987). Abnormalities in mitochondrial and microsomal
function along with the possible leakage of hydrolytic lysosomal enzymes from
peroxidized lysosomal membranes may provide sufficient organelle dysfunction to be
deleterious to the maintenance of normal cell integrity (Peters et al., 1985). At the present
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time it is unknown whether any of these functional abnormalities in subcellular organelles
(lysosomes, mitochondria, microsomes) demonstrated experimentally are
pathophysiologically significant in producing the chronic liver damage observed in the
human conditions of Fe overload.
Another mechanism of liver damage in Fe overload is that proposed by Weintraub
et al. (1985), in which excess tissue Fe may provide a direct stimulus to collagen
biosynthesis and lead to the development of fibrosis without invoking preceding Femediated cellular injury. None of these postulated mechanisms is mutually exclusive, and
all may be operative concomitantly. Further experimental studies are necessary to
determine the relative importance of these various proposed mechanisms as they relate to
the tissue damage seen in patients with Fe overload.
Animal studies
Ionic Fe is known to stimulate lipid peroxidation in vitro. Lysosomal fragility has
been examined in rats fed diet containing elemental carbonyl Fe; increased lysosomal
fragility correlated with increasing hepatic Fe concentrations (Britton et al., 1987).
Studies with lysosomes have suggested that the increased membrane fragility is mediated
by Fe induced peroxidative injury to lysosomal membranes (Mak and Weglicki, 1985;
O'Connell et al., 1985). Iron induced membrane lipid peroxidation of mitochondria and
microsomes, leading to functional insufficiency with subsequent cell injury and cell death
is another mechanism though not mutually exclusive.
The effect of Fe overload on hepatic mitochondrial oxidative metabolism has been
studied in rats fed dietary carbonyl iron, and in rats to which Fe was injected. There is
evidence of Fe-induced lipid peroxidation in hepatic mitochondria and microsomes from
rats with chronic Fe overload (Bacon et al., 1983). Associated functional abnormalities in
hepatic mitochondria showed a decrease in respiratory control due to an irreversible
inhibitory defect in electron transport (Bacon et al., 1985). Since the electron transport
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chain is imbedded in the inner mitochondrial membrane, it seems possible that a change in
membrane properties induced by lipid peroxidation might be responsible for the observed
defects (Britton et al., 1987).
Associated anomalies in hepatic microsomal function have been reported including
drastic reductions in concentration and activity of cytochrome P-450 (Nordman et al.,
1987). It could be that the Fe-initiated lipid peroxidation decomposes the lipid envelope
in which cytochrome P-450 is embedded, destroying its functional integrity, as has been
theorized for other lipid peroxidation initiators (Recknagel and Glende, 1973). There is
also evidence of largely decreased rotational mobility of the P-450 protein, in Fe-catalyzed
peroxidized rat liver microsomes. This motion of the protein seems to be needed to allow
the electrons transfer in the system (Richter, 1987). Iron overload in experimental animals
can result in lipid peroxidation in vivo, as evidenced by increased alkane exhalation,
TBARS production and lipid conjugated dienes. Iron overload produced induced
parenterally with iron dextran increases lipid peroxidation in rats, measured as exhaled
ethane and pentane (Dillard and Tappe!, 1979). Several studies report elevated levels of
TBARS in liver and other tissues of rats given injections of iron d~xtran (Britton et al. ,
1987). Britton's group has reported increased levels of TBARS in the livers of rats fed
dietary carbonyl iron (Britton et al., 1987). The presence of elevated levels of conjugated
dienes in hepatic microsomes, and increased amounts of urinary thiobarbituric acid
reactants in rats fed dietary carbonyl iron has been confirmed (Meydany et al., 1987).
Studies in patients
The key question of whether lipid peroxidation occurs in vivo in patients with Fe
overload has not yet been resolved. However, several studies point in that direction. It
has been reported that erythrocytes from Fe-loaded thalassemic patients show an
increased susceptibility to in vitro lipid peroxidation when exposed to a peroxide
challenge (Britton et al., 1987). Homogenates of Fe-loaded spleens from patients with
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thalassemia produced greater amounts of TBARS and fluorescent products than those
from patients without Fe overload, when incubated in vitro (Britton et al., 1987).
Elevated levels of activity of several lysosomal enzymes, have been observed in
liver biopsies of patients with Fe overload (Britton et al., 1987). Lysosomes isolated from
liver biopsy specimens from patients with Fe overload have increased membrane fragility
in vitro (Peters et al., 1985); this increase in fragility returns to normal in patients with

hemochromatosis after chronic phlebotomy therapy.
People suffering different degrees of Fe overload might be affected not only by
direct lipid peroxidation compromising the cells survival, but also by indirect lipid
peroxidation effects on metabolic pathways. The metabolism of xenobiotics by the
cytochrome P-450 system of enzymes in hepatic tissues could be one of them. Not much
is known about the level of Fe overload at which such indirect effect could take place in
humans, but relatively subtle changes in membrane constitution could affect the active site
of membrane bound enzymes (Richter, 1987).
Effect in glutathione peroxidase activity
Soluble enzymes can also be affected by Fe overload. There is evidence of
decreased Se-dependent GSHPx activity in animals under Fe overload (Lee et al., 1981;
Reffet et al., 1986). Reffet et al. (1986) induced dietarily Fe overload in lambs and
observed
decreased activity of Se-dependent glutathione peroxidase (GSHPx) in liver but
...______
not in lung or spleen. Lipid peroxidation, based on measurement of malonaldehyde
formation in homogenates of liver, spleen or lung, was not affected by the dietary Fe.
Lee et al. (1981), using male Sprague Dawley rats, evaluated GSHPx activity during
intake of excess dietary Fe and Se deficiency; a decrease in liver Se-dependent GSHPx
activity was observed. Liver Se-dependent GSHPx decreased markedly during Se
deficiency. Lipid peroxidation, estimated by the thiobarbituric acid method, was elevated
in the Fe overloaded animals compared with controls. No explanation for the observed
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effect of Fe overload on Se-dependent GSHPx is available.
IRON DEFICIENCY
In considering the effect of Fe deficiency on the activities of various enzymes it is
apparent that depletion of enzymes and their repletion is largely tissue specific. Iron
deprivation might affect most severely those tissues which have a rapid growth and rate of
cell division.
Pascoe et al. ( 1983) have demonstrated that dietary deprivation of Fe can decrease
the intestinal cytochrome P-450 content and activity.

~y

contrast, liver cytochrome P~450

has been shown to be highly resistant to Fe deficiency (Dallman and Goodman, 1971).
Relatively little is known of the effect of Fe deficiency on the functions of peroxidases.
Lowered levels of GSHPx have been described in Fe-deficient rabbits (Rodvien et al.,
1974) and man (MacDougall, 1972). The basis for such a decrease is not clear since
GSHPx is a Se containing enzyme.
Rat pups are popular experimental models for the study of the role of dietary Fe in
lipid metabolism. Hypertriglyceridemia and fatty livers have been observed in pups of Fedeficient rats, and Fe supplementation reverses the lipid accumulation. A feasible
explanation relies in the requirement of Fe for the synthesis of carnitine, an essential
cofactor for oxidation of normal fatty acids (Bartholmey and Sherman, 1985).
Iron has also an integral role in the production of unsaturated fatty acids; in rats
fed a Fe-deficient diet, the ratio of mononunsaturated to saturated fatty acids in tissue
lipids is reduced. This seems to be a consequence of a reduction in the activity of an Fecontaining desaturase enzyme complex found in several tissues (Larkin et al., 1986).
Also in pups, it has been observed that Fe deficiency can alter the fatty acid composition
of the brain.
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SELENIDM DEFICIENCY
Glutathione peroxidase
The enzyme glutathione peroxidase (GSHPx) was discovered in erythrocytes
(Mills, 1957). It was then described as capable of protecting hemoglobin from oxidative
breakdown by catalyzing the reduction of hydrogen peroxide to water (Mills, 1957). A
decade later, the enzyme was also found to catalyze the reduction of organic
hydroperoxides formed from unsaturated fatty acids (Little and O'Brien, 1968). With this
new finding, a far broader role for the enzyme in detoxication and in the protection of cell
membrane against peroxidative damage was established. GSHPx is considered an
important cell line of defense against lipid peroxidation (Wendel, 1980).
In the early 1970s, Se was discovered as an integral part of GSHPx (Rotruck et
al., 1973; Flohe et al., 1973); the essentiality of this element was then established.
Subsequent studies have shown that the activity of GSHPx in animal tissues is directly
related to the availability of dietary Se (Smith et al., 1974; Hafeman et al. , 1974; Knight
and Sunde, 1987). In rats fed a diet with less than 0.02 ppm Se, liver GSHPx activity
decreased to undetectable levels by day 21 (Knight and Sunde, 1987). Feeding rats for
28 days with a Se-deficient diet, Reddy and Tappel (1974) found a significantly lower
GSHPx activity in the unsupplemented rats. Nalini et al. (1976), using a 0.014 ppm Se
diet, found a slight decrease in the intestinal mucosa after 24 days of treatment. They
concluded that the slow decline in enzyme activity may be explained by the accessibility of
residual dietary Se to the mucosal cell. Pascoe et al. (1983) found significantly lower
GSHPx activity in the intestinal cells of rats after 3 days of a Se-deficient diet (0.01 ppm
Se).
In 1976, it was discovered that Se-deficient rat liver had GSHPx activity that was
independent of Se (Lawrence and Burk, 1976). This activity is catalyzed by one or more
of the GSH-S-transferases (Prohaska and Ganther, 1977). The activity of this Seindependent GSHPx is not decreased in a Se-deficient diet. The Se containing enzyme
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utilizes hydrogen peroxide and organic hydroperoxides as substrates, whereas the Seindependent GSHPx has a far greater specificity for organic hydroperoxides. It has been
emphasized that there is potential error associated with assessment of the Se status of an
animal by measuring GSHPx with organic hydroperoxides in tissues having Sedependent and Se-independent enzymes (Scholz and Hutchinson, 1979). The use of
organic hydroperoxides such as cumene-hydroperoxide or t-butyl hydroperoxide for the
determination of Se-dependent GSHPx is not recommended unless the absence of GSH-Stransferases has been confirmed chromatographically. This is the case in intestine where
the absence of Se-independent GSHPx was confmned (Lawrence and Burk, 1976).
Influence on xenobiotics metabolism
There is evidence that in severe Se deficiency there may be decreases in some
forms of hepatic cytochrome P-450, especially when inducers of the enzyme such as
phenobarbital are administered to the rats. Se seems to be required for the maintenance of
one or more forms of cytochrome P-450 (Burk and Correia, 1981). However, Reiter and
Wendel (1983, 1984) did not observe any significant change in the cytochrome P-450
activity assayed with aniline (hydroxylation) or with aminopyrine (demethylation) after 2
and 6 months of feeding a Se-deficient diet. They detected, instead, a 330% increase in
the cytochrome P-450 activity when assayed with 7-ethoxycoumarin (deethylation); and a
240% increase in heme oxygenase activity, an enzyme involved in heme catabolism.
These authors observed that a dietary Se content of 0.01 ppm was required for the
induction of these enzymes; with a diet of 0.05 ppm Se, they failed to induce any
significant changes. These reports indicate that the overall influence of Se on xenobiotic
metabolism by cytrochrome P-450 is likely to be very complex.
Se deficiency causes and increase in hepatic glutathione S-transferase activity
(Lawrence et al., 1978). It also increases the synthesis of glutathione (Hill and Burk,
1982). These should increase the ability of the liver to detoxify substances via the
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glutathione conjugation pathway (Lin et al., 1984).
Cancer
Epidemiological evidence shows an inverse relationship between dietary Se intake
and certain forms of cancer in humans, especially colon, rectum, and breast cancer.
Some studies also show an inverse association between cancer incidence and Se
concentration in local forage plants and in human blood. An increased incidence of those
cancers in geographic areas where Se is deficient has been demonstrated in the United
States and globally (Jacobs, 1977; Schrauzer, 1976).
The association between levels of Se in serum and subsequent risk of
gastrointestinal cancer was investigated in Finland, an area of the world very low in Se.
Men and women initially free of cancer were studied, and it was found that subjects with
a low level of Se had an elevated risk of cancer of the upper gastrointestinal tract (Knekt et
al., 1988).
It is possible that Se deficiency does not cause cancer but increases the
susceptibility to cancer induction (Whanger, 1983). Several laboratory investigations
have shown that Se prevents or retards the genesis of a number of chemically and virally
induced or transplanted tumors (Griffin, 1979). In general, Se will counteract, to varying
degrees, the effects of chemical carcinogens used to produce lesions of the skin (eg.,
coaltar); liver (eg., aflatoxin B 1), mammary gland (eg., nitrosoureas); and intestinal tract
(eg., nitrosamine, dimethyhydrazine, and azoxymethane) (Whanger, 1983).
Mechanisms of action
Se may influence carcinogenicity by interfering with the activity of enzymes
involved in metabolic activation of precarcinogens as well as by enhancing the
detoxication pathway (Lin et al., 1984). As a constituent of GSHPx, Se can affect the
GSHPx concentration and activity in the cell and, thereby, affect the cellular GSHPx
defense against the deleterious effects of hydroperoxides (free-radicals). However, no
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direct relationship between lowered Se-dependent GSHPx protection against lipid
peroxidation and cancer initiation or promotion has been established.
Other effects in man
The most severe Se deficiencies in free-living humans have been reported in
China. In other parts of the world, researchers observed similarly low Se status in
patients treated with either therapeutic diets low in Se or with parenteral alimentation.
Keshan disease is the first human disease shown to be related to Se deficiency. It is a
cardiomyopathy of children and young women in China that occurs in regions where Se
levels are extremely low; and prophylactic Se supplementation can eradicate the disease
(Chen et al., 1980).
Several cases of cardiomiopathy associated with low Se levels have been reported
in patients nourished parenterally. The biochemical function of Se associated with the
cardiomiopathy is unknown (Burk, 1983). However, frank Se deficiency does not occur
in most of the world.

Se deficiency has been also associated with atherosclerosis. Se

deficiency in rats results in reduced aortic prostacyclin production, probably due to
hydroperoxide-induced inactivation of prostacyclin synthetase. It also increases plasma
low-density-lipoprotein cholesterol. Such actions are likely to contribute towards the
atherosclerotic process (Parnham et al., 1987).

LIPID PEROXIDATION
A free-radical is a chemical compound that has an odd number of electrons and is
therefore generally highly reactive and unstable. Free radicals can be produced in the cells
and tissues of our bodies by radiation, and reduction-oxidation (redox) reactions
involving the transfer of an electron. These redox reactions can be catalyzed by transition
metal ions or by enzymes (Slater et al., 1987).
Biological systems find, in molecular oxygen, both benefit and detriment. Thus,
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while being useful to aerobes as an electron sink for energy-yielding reactions and as a
reagent for numerous metabolic transformations involving oxidation, it simultaneously
exerts toxicity. All oxidative damage in biological systems arises ultimately from
molecular oxygen (DiGuiseppi and Fridovich, 1983). There is a growing awareness that
membrane lipid peroxidation may be the underlying cause of many forms of oxygen
toxicity. The reactive species which initiates lipid peroxidation in biological systems has
not been identified. The nature of the oxygen involved in the process is still under
investigation. The hydroxyl radical HO·, superoxide anion 0·2, singlet oxygen 102, and
the hydroperoxy radical HOO· have all been considered (Wills, 1985).
Lipid peroxidation is a free-radical mediated process that can result in acute cell
injury if the normal protective mechanisms of the cell are overwhelmed. In a cellular
context, lipid peroxidation often utilizes as substrates the polyunsaturated fatty acids
(PUFA) in membranes (plasma membrane, endoplasmic reticulum, mitochondrial
membrane, etc) (Slater et al., 1987). In a process called initiation, PUFA are converted
via H. abstraction into lipid free-radicals. This process is catalyzed by the presence of
trace amounts of transition metals such as Fe. R· + PUFA (H)---- RH + PUFA. The
lipid free-radicals are in turn oxidized by molecular oxygen to lipid peroxy radicals.
PUFA + 02---- PUFAOO·. PUFAOO· radicals are able to extract H· from new PUFA
(H) atoms in a process referred to as propagation. Propagation stages involve bondrearrangement to give diene conjugates (Slater et al., 1987).
The important role of Fe in both enzymatic and non-enzymatic lipid peroxidation
has been confirmed by numerous studies. However, the mechanism by which Fe
promotes lipid peroxidation has not been elucidated. A generally accepted theory is that
Fe may serve as a catalyst for the formation of the highly reactive hydroxyl radical (·OH)
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which initiates lipid peroxidation.

As a catalyst, Fe functions as an electron acceptor

from 02·- as well as a Fenton's Reagent for the generation of ·OH from H202.
02·- +Fe3+ --- 02 + Fe2+
202·- + 2H+ --- 02 + H202
H202 + Fe2+ --- Fe3+ + OH +·ORThis sequence of reactions is often called the superoxide-driven Fenton's reaction (Minotti
and Aust, 1987).
Other important theories are also being investigated (Minotti and Aust, 1987);
among these, one proposes that Fe, itself, is the actual initiator of lipid peroxidation. In
this theory it is proposed the envolvement of oxygen to bridge Fe3+ and Fe2+ in a Fe2+dioxygen-Fe3+ complex. It is suggested that different electric charges in Fe complexes
creates "a sort of nidus" for oxygen, capable to capture electrons from unsaturated lipids
or other oxidizable substrates.
Cancer
There is general agreement that tumor cells are formed conforming to the theory of
initiation-promotion. Compounds which cause initiation are usually thought to bind DNA
and to cause irreversible molecular damage. Promoters, on the other hand, are thought to
bind to cell membranes and be reversible. Promoters are thought to enhance the activity
of initiators. Some agents act as both initiators and promoters (eg., some chemicals and
radiation). Many think the two-step mechanism occurs with all carcinogenic agents, but
chemical carcinogens most clearly follow this example. Both initiators and promoters
involve free-radicals (Weinstein, 1981 ).
Chemical alterations and damage to DNA may be produced in the various steps of
lipid peroxidation. During initiation, as a direct reaction between oxygen radicals and
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DNA, and during propagation with the reaction between DNA and the lipid radicals.
Here, DNA acts as a radical scavenger/antioxidant, since it stops the lipid peroxidation
process at either level of initiation or propagation. A third mechanism could be the
reaction of DNA with non-radical products of lipid peroxidation (Vaca et al., 1988).
However, experimental evidence for the involvement of the interaction between
lipid peroxidation products and DNA in the initiation and promotion steps of
carcinogenesis has not yet been presented and the proposal for such a causative
relationship is primarily based on the effects of dietary fats on cancer incidence and on the
observation that the most important human defense mechanisms against mutagens and
carcinogens are the same as those that operate against oxygen radicals and lipid
peroxidation (Slaga et al., 1983). Among them, Se and glutathione peroxidase has been
found to have antimutagenic and anticarcinogenic activity (Knuutila, 1984 ). The
supposition that oxygen-free-radicals are involved in carcinogenesis is based on recent
exciting but controversial evidence from a number of diverse studies. Much research
emphasis linking free-radicals and cancer has focused on intermediates of oxygen
reduction such as superoxide anion and hydroxyl radical. Although the peroxyl radical
has received less attention, it may be just as important biologically as reduced oxygen
intermediates (Marnett, 1987).
There is a lack of suitable methods which can be utilized to study free-radical
reactions and the formation of marker products to free-radical reactions. The progress
made in determining oxidative damage to DNA has been mostly in vitro. The analysis of
in vivo models seems a very difficult task. In spite of the growing collaboration between

free-radical researchers and carcinogenesis investigators, it is generally felt that it will be
experimentally much more difficult to demonstrate a connection between oxygen radicals
and carcinogenesis than it has been to make the same connection between certain
xenobiotics and cancer.
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Aging and atherosclerosis
The idea that lipid peroxidation is responsible for aging phenomena has attracted
many researchers. This hypothesis is supported by the accumulation of lipofuscin
granules in the cellular matrix during the aging process. However, the granules, even if
they originate from lipid peroxidation, seem to be quite inert and without any effect on cell
regulation (Tappe!, 1970).
Lipid peroxidation may be linked to the etiology of atherosclerosis. Atherogenesis
is enhanced by substances capable of irritating the arterial wall. A possible constant
source of irritating compounds is the reaction of molecular oxygen with the
polyunsaturated compounds present in serum and arterial-wall lipids. Lipid peroxidation
could directly damage the endothelial cells promoting the process of atherosclerotic lesion
formation (Henning and Chow, 1988).
Lipid peroxidation measurement
As already discussed, lipid peroxidation in biological systems consists of a
complex series of reactions which include many intermediates and products. A number of
analytical techniques which measure some of these intermediates and products have been
applied to detect lipid peroxidation in vivo. Substances derived from peroxidizing lipids
that have been measured in vivo include ethane and pentane, fluorescent products,
thiobarbituric acid reactive material, lipid hydroperoxides, lipid hydroxy acids, aldehyde
products, adducts of aldehydes with lipid and protein, and lipid conjugated dienes
(Kappus, 1985). To determine whether lipid peroxidation has occurred in vivo, it is
essential to measure a peroxidation product which was produced in vivo. This involves
employing analytical procedures which prevent any artifactual peroxidation from taking
place during sample processing. The thiobarbituric acid test (TBA) involves reacting the
sample with TBA under acidic conditions and elevated temperatures (80-lOOoC), and
measuring the absorbance at 535nm. In biological systems, malonaldehyde (a breakdown
product of lipid peroxidation) appears to be the predominant TBA reactant, although other
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substances can react with TBA (TBARS) and contribute to the absorbance at 535 nm.
Britton et al. ( 1987) uses homogenization of liver samples with 5% trichloroacetic
acid to denature proteins, allowing both proteins and the lipids associated with them to be
removed by · centrifugation. This leaves a supernatant which is essentially free of
substrate for any Fe-induced peroxidation, which may occur during the TBA assay itself.
Alternatively, when tissue samples are directly assayed in the TBA test, the use of
butylated hydroxytoluene in the assay mixture has been recommended to prevent Feinduced lipid peroxidation (Buege and Aust, 1984).
Because of the growing importance of lipid peroxidation in the biomedical field,
there is an increasing need for reliable methods to detect these processes in vivo .
Pompella et al.

(1987) compared the methods more commonly used in various

laboratories to detect lipid peroxidation in vivo: measurement of the malonaldehyde
content of the liver; detection of diene conjugation absorption in liver phospholipids;
measurement of the loss of polyunsaturated fatty acids in liver phospholipids; and
measurement of the carbonyl functions formed in the acyl residues of membrane
phospholipids. They wanted to determine if the methods correlate and to test the
reliability of each individual method. Correlations among the values obtained with these
methods were high significant statistically, indicating that the procedures measure lipid
peroxidation in vivo with similar reliability.
THE INTESTINAL TRACf
Relevance of extrahepatic metabolism
The interfaces between man and his environment are several, and the
gastrointestinal tract is a major interface. The small intestine offers, itself, a total epithelial
surface area of 2,000 ft2 (Hinkle, 1972). Food and drink represent the most complex
mixture of chemicals to which humans are obligatorily exposed, and many sources of
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occupational exposure may also end up in the gastrointestinal tract. The gastrointestinal
mucosa is a site of extra-hepatic drug metabolism. It may also play a role in excretion: by
producing conjugates of absorbed compounds which are returned to the intestinal lumen
by excretion or cell sloughing and therefore never reach the circulatory system (V ainio
and Hietanen, 1980). The rate of extrahepatic xenobiotic metabolism may not be as high
as in the liver and the total capacity may also be lower, but human exposure to both
environmental and occupational foreign compounds is often a chronic situation in which
only small quantities at a time enter the body. Since almost all absorption and digestion of
food and water occurs in the small intestine, the study of metabolism at the intestinal level
becomes relevant.
In the intestinal mucosa, as in the liver, several of the metabolic biotransformation
reactions are catalyzed by the microsomal mixed function oxidase (MFO) system, of
which cytochrome P-450 and NADPH cytochrome P-450 reductase are key components.
However, the cytochrome P-450 content of the intestine is much less than that of the liver;
0.1 vs 0.9 nmol/mg microsomal protein, respectively (Vainio and Hietanen, 1980).
Previous studies indicate the existence of a gradient in mucosal MFO activity from the
duodenum to the colon that closely parallels a similar gradient in intestinal absorptive
capacity. In addition, the most mature epithelial cells at the mucosal villous tips, pivotal
in absorption of intraluminal constituents, are also the richest in cytochrome P-450
content and related MFO activity (Pascoe et al., 1983).
More than 20 cytochrome P-450 isozymes have been purified, and according to
some investigators, the total number of existent cytochrome P-450 isozymes could be
potentially enormous (Lu and West, 1980). These studies have been done in several
mammalian species and in fish. The isozymes vary with the species, organ, tissue, type
of cell (in a common tissue), sex, and age of the organism (Lu and West, 1980). These
isozymes can be induced by a wide spectrum of natural and synthetic substances in the
environment and diet as well as by products of the normal physiological processes.
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Induction of the intestinal cytochrome P-450 enzymes due to dietary manipulation has
been the subject of several investigations (Salbe and Bjeldanes, 1985). Intestinal MFO
activity is minimal in rats fed a semi-synthetic diet and which have been starved for one to
three days. It has been suggested that the major part of drug metabolising enzyme activity
in the gut is due to exogenous inducers in the diet, flavones contained in standard
laboratory chow for instance, are intestinal cytochrome P-450 inducers (Wattenberg,
1971). Most cancers develop in epithelial tissue (Cone and Nettesheim, 1973). Thus,
the events that take place at the gastrointestinal mucosa, and that could eventually affect
the systems that control the differentiation and proliferation of these epithelial cells, are
extremely important.
More recently, the activation of several kinds of substrates, some of them
intestinal carcinogens, has been associated with cooxidation with prostaglandin H
synthetase (PHS). PHS activity is relatively high in many extra-hepatic tissues which are
low in MFO activity. Krauss and Eling (1984) proposed that PHS could be an alternative
or additional enzyme system for the metabolic activation of compounds which exhibit
extra-hepatic toxicity and carcinogenicity.
Intestinal glutathione peroxidase
The presence of hydroperoxides in the cell controls the balance between the
lipoxygenase and cycloxygenase pathways (Reddy and Massaro, 1983). Since both, Sedependent and Se-independent GSHPx can effectively decompose fatty acid
hydroperoxides, they may play an important role in the control of the presence of cellular
hydroperoxides, and in turn, in the modulation of the cyclooxygenase and lipoxygenase
pathways in vivo.
All the above described events are happening in an epithelial tissue which has an
especially fast turnover of only 36 hours (Loehry et al., 1969). It has been suggested that
rapidly regenerating tissues such as the intestinal mucosa exhibit inordinately high Se
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turnover characteristics (Pascoe et al., 1983). The intestinal cell apparently derives its Se
supplement solely from the diet whereas the liver may derive its Se from body stores
(Pascoe et al., 1983). However, Nailini et al. (1976) observed a slow decline in GSHPx
activity in the intestinal mucosa after 24 days of a Se-deficient diet. Reddy and Tappel
(197 4) reported a 50% decrease in GSHPx activity of the intestinal mucosa of of rats after
28 days of feeding a Se-deficient diet. These are much more slower rates of decrease than
those reported for liver.
The relatively fast cell turnover of the intestinal mucosa also makes this epithelia
particularly susceptible to the action of free-radical.s and radiation. This is probably true
also for mutagens and carcinogens which can originate from the diet and exert their
toxicity through the generation of oxygen radicals (Ames, 1983). The epithelia of the
gastrointestinal tract is then unavoidably exposed to oxygen radicals that are generated in
the epithelial cells of the mucosa and also within the lumen (Grisham et al., 1987;
Granger et al., 1986). These radicals could, in turn, lead to the oxidation of fat in cellular
membranes of the epithelia by a lipid peroxidation chain reaction, especially if the cell's
regular protection against lipid peroxidation is reduced.
These dangerous reactive products must be promptly eliminated, and this is
accomplished in cells by several lines of defense including superoxide dismutase which
converts 02·- into H202 as well as catalase and peroxidases which convert H202 into
H20 plus 02 (Robinson and Thomson, 1983). As discussed before, GSHPx has central
importance in protecting against the pro-oxidative consequences of metabolic activation of
oxygen (generation of OH) via the reduction of H202 in the cell. It aids in blocking the
free-radical formation and subsequent attack of membrane phospholipids and critical
proteins (Mills, 1957, Little and O'Brian, 1968). Since the intestinal mucosa lacks Seindependent GSHPx (Levander, 1982), its acute dependency on intraluminal sources of
Se may be a relevant factor for the antiperoxidative defense of the tissue by Se-dependent
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GSHPx.
Intestinal Fe-overload
Compared with liver, much less information about intestinal Fe-overload is
available. Rats injected with iron sorbitol citrate did not have a significant increase in the
concentration of Fe in the Fe-loaded intestinal epithelial filtered homogenates (Richmond
et al., 1972). This could be due to a relatively low total dose of injected Fe (40 mg), and
to the fact that the rats were killed 10 days after the last Fe injection.
Gavino et al. (1984 ), working with iron dextran injected rats, found increased
levels of Fe in intestinal rings (1cm piece of small intestine 5cm distal to the stomach).
But, they did not find increased lipid peroxidation (measured as total ethane and pentane)
in those rings. However, the intestinal mucosal tissue makes up a very small fraction of
these rings which would mask any effects of Fe-overload on this tissue.
In Fe overloaded rats fed a laboratory chow diet containing 2% carbonyl iron for 6
months, it was observed that the excess of Fe accumulated in hepatocytes lysosomes after
Fe-loading which is released from the lysosomes into bile. Biliary Fe is then excreted in
the intestinal tract. It is assumed that, similar to biliary copper, the excreted Fe is poorly
absorbed by the intestine after biliary excretion (Le Sage et al., 1986).
It has been suggested that carbonyl iron can be absorbed from the duodenal
mucosa without the participation of ferritin and transferrin (Nakamura et al., 1988).
Also, the role of Fe in producing oxidant-mediated injury to the gastric mucosa in vitro,
was investigated. It was concluded that Fe, particularly intracellular Fe, plays an
important role in mediating oxygen radical damage to gastric mucosal cells. OH.,
produced by the Fe catalyzed Haber-Weiss reaction, seems to be a main mediator of
oxidant induced cytotoxicity to gastric mucosal cells in vitro (Hiraishi et al., 1988).
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BROMOTIUCHLOROMETHANE
Bronaonichloronaethane
Bronaotrichloronaethane (CBrCl3) as tetrachloronaethane (CC14), chloroform
(CHC13), and several other halonaethanes are con1n1on environnaental pollutants. There is
plenty of evidence that these three hepatotoxins are lipid peroxidation initiators and they
require naetabolic activation by cytochronae P-450 to exert toxicity. Cytochrome P-450
cleaves the halogen-carbon bond forming a halomethane radical as a reaction product.
The free-radicals in turn initiate a peroxidative deconaposition of liver cell structural lipids
leading to liver necrosis (Recknagel and Glende, 1973). Anaong other sources of
evidence, the use of inhibitors or inducers of cytochronae P-450 drastically reduces the
toxicity of CC14. These known hepatoxins are also suspected as carcinogens (Sittig,
1985). Less is known about the naechanisna by which those halonaethanes naay participate
in the process of carcinogenesis, but as discussed before, lipid peroxidation, itself, and
sonae of its by-products are inaportant potential initiators and pronaoters of cancer.
It has been denaonstrated that CBrCl3 beconaes covalently bound to DNA after
bioactivation. This is an inaportant piece of information since one of the prevailing
theories of chenaical carcinogenesis is that the initiating agents interact with DNA (Direnzo
et al., 1982). Bronaonichloronaethane is a better lipid peroxidation initiator than CCl4 and
CHCl3 probably due to a relatively lower energy requirenaent for the cleavage of the C-Br
bond to produce the ·CC13 free-radical (Reck .. nagel and Glende, 1973). It has an oral
LDso in rats of 200 nag/kg conapared with an LDso of 2800 nag/kg for CCl4 (NIOSH,
1985).
Higher in vitro naalonaldehyde production in rat liver naicrosonaes exposed to
CBrCl3 as conapared with that of liver naicrosomes exposed to CCl4 has been reported
(Slater and Sawyer, 1971 ). In vitro assays with tissue slices of intestinal tract, CBrCl3
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initiates lipid peroxidation. It has been suggested that CBrCl3 could act at organs other
than liver (Gavino et al., 1984; Fraga et al., 1987). However, no in vivo work has been
done to elucidate this any further.
Se and Fe influence on bromotricholomethane
High levels of Se are known to protect against CCl4 toxicity (Benedetti et al., 1979).
While Se deficiency and the consequent decrease on Se-dependent GSHPx activity
augments the toxicity of lipid peroxidation initiators such as Fe overload (Dougherty et
J

al., 1981), or CCl4 (Hafeman and Hoekstra, 1977), the potential effect of Se deficiency
in BrCl3C toxicity has not been assayed in vitro or in vivo. On the other hand, induction
of GSHPx activity due to peroxidative stress caused by ozone exposure, vitamin E
deficiency and dietary autoxidized lipids has been observed in different tissues including
the intestinal tract (Reddy and Tappel, 1974). By contrast, GSHPx activity reduction has
been reported under Fe overload (see Fe overload section) and due to exposure to 2,3,7 ,8tetrachlorodibenzo-p-dioxin (TCDD) (Hassan et al., 1985) which is also a peroxidative
stressor.
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CHAPTER ill
MATERIALS AND METHODS
ANIMAL HUSBANDRY

Animals
Male Sprague-Dawley rats (Simonsen Laboratories, Gilroy, California) were
housed individually in stainless steel cages with wire mesh bottoms and fronts in a room
maintained at 25°C and 45% humidity with a 12h light-dark cycle. Food and water were
available ad libitum.
Diets
A torula yeast diet was prepared as presented in Table 1. The Fe and Se contents
of this diet were 232 ppm and less than .05 ppm, respectively.
A semi-synthetic diet Fe- and Se-deficient was prepared as described in Table 2.
A diet with a reduced concentration of com-starch substituted with carbonyl iron was also
prepared as described in Table 2.
When supplemented, Fe (75 ppm as FeCl3 -6H20) and/or Selenium (0.5 ppm as
Na2Se03) were added to the deionized water. Otherwise, deionized water virtually free of
Se.and Fe (<1 ppb) was available.
Fe was determined spectrophotometrically using ferrozine for the Fe assay
(Stookey, 1970) and spectrofluorometrically using 2,3-diaminonaphthalene for the Se
assay (Koh and Benson, 1983).
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Table 1--Diet composition, experiment 1
Ingredienta

%

Torula yeast
Sucrose
Com Oil
Mineral mixture b
Vitamin mixturec

30.0
59.0
7.0
3.0
1.0

aIngredients were purchased at ICN Biochemicals Incorporated, Cleaveland, OH.
bcAs specified on Nutrient Requirements of Laboratory Animals (The National
Academy of Sciences, 1978). The mineral mixture (Fe and Se free) contained in glkg diet:
Dicalcium phosphate, 18.41; Magnesium oxide, 0.67; Potassium citrate, 7.70; Potassium
sulfate, 1.82; Sodium chloride, 1.27; Chromium potassium sulfate, 0.003 ; Copper
carbonate, 0.009; Sodium fluoride, 0.002; Potassium iodide, 0.0002; Manganese
carbonate, 0.11; Zinc oxide, 0.015. The vitamin mixture contained in mglkg diet: Vitamin
A acetate, 100.00; Calciferol (850,000 U/gm), 11.80; Alpha tocopherol (250 I.U./gm),
120.00; Menadione, 0.50; Choline chloride, 10.000.00; Folic acid, 10.00; Niacin,
200.00; Calcium pantothenate, 80; Riboflavin, 30.00; Thiamine, 40.00; Pyridoxine
hydrochloride 60.00; Vitamin B-12, 50.00.

Table 2--Diet composition, experiments 2, 3 and 4
Ingredienta
Com-starch
Dextrose
Casein
Corn oil
Mineral mixtureb
Carbonyl ironC
Vitamin mixtured
Methionine

Regular
56.0
17.5
12.0
10.0
3.0
0.0
1.0
0.5

Iron overloaded
54.0
17.5
12.0
10.0
3.0
2.0
1.0
0.5

anextrose, oil and corn-starch were purchased at local stores. All other ingredients
were purchased from ICN Biochemicals, Inc., Cleveland, OH.
bdThe compositions of the vitamin and mineral mixtures are shown in Table 1.
C99% Fe as reduced pentacarbonyl iron, Sigma Chemical Company.

28

EXPERIMENfAL DESIGN
Experiment one
Rats (210-230g) were fed the torula yeast diet for 20 days. The Fe and Se
contents of the diet were 232 ppm and less than 0.05 ppm respectively. Fe overload was
induced in some of the animals by intramuscular injections of iron dextran (100 mg Fe/ml;
Sigma Chemical Co.) up to a total of 75 mg Fe per 100 g body weight, following the
system used by Dillard et al. (1984 ). The dose was divided in three equal injections
delivered on days 4, 9, and 14 of the experiment. The remaining rats were sham-injected
with physiological saline. Animals were randomized into 4 groups of 15 animals each: Se
and Fe supplemented animals (+Se+Fe), were supplied Se in the water as described
above; Se-deficient and Fe supplemented animals (-Se+Fe), were supplied deionized
water. Se supplemented and Fe overloaded animals (+Se++Fe), were supplied Se in the
water and injected with iron dextran; and Se-deficient and Fe overloaded animals
(-Se++Fe) were supplied deionized water and injected with iron dextran. The animals
were fed their respective diets for 20 days. On days 15-19 of the experiment, five animals
from each of these groups were treated with CBrCl3 (9.9 mM/ml) diluted in 0.5 ml of
mineral oil (dose I: 0.05 j..!l/kg b.w./day) and five more with CBrCl3 (dose II: 0.5 j..!l/kg
b.w./day) . The five remaining animals from each group were designated as controls and
gavaged with mineral oil only. All the animals were killed on day 20, 24 hr after their last
CBrCl3 dose.
Experiment two
For two months, rats (70-90 g) were fed the semi-synthetic Fe and Se-deficient
diet or the Fe overloaded diet (as described by Bacon et al., 1986) and Se-deficient diet.
The Fe and Se content of this diet was 12 ppm, and less than 0.05 ppm respectively.
Animals were randomized into 4 dietary groups of 10 animals each: Se and Fe
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supplemented animals (+Se+Fe) were given Se and Fe in the water; Se-deficient and Fe
supplemented animals (-Se+Fe) were given only Fe in the water; Se supplemented and Fe
overloaded animals (+Se++Fe), were fed the carbonyl iron diet and supplemented with Fe
and Se in the water; Se-deficient and Fe overloaded animals (-Se++Fe), were fed the
carbonyl iron diet and supplemented with only Fe in the water. Bromotrichloromethane
(9.9 mM/ml) diluted in approximately 0.5 ml of mineral oil was given by gavage, at a
dose of 5.0 jll/k:g b.w./day, for five consecutive days, to 5 animals in each of the different
dietary groups. The remaining five animals in each dietary group, were sham-gavaged
with mineral oil and designated as control groups. Twenty four hours after the last
gavage the animals were sacrificed.
Experiment three
Rats (250-275g), were fed the semi-synthetic Fe- and Se-deficient diet (Table 2).
The Fe and Se contents of this diet were 10 ppm and less than 0.02 ppm. The availability
of a source of casein exceptionally low in Se content (from ICN Biochemicals, Inc.,
Cleveland, OH) allowed us to prepare a diet with a particularly low Se content. Animals
were randomized into 4 groups of 5 animals each:

Se and Fe supplemented animals

(+Se+Fe) given Se and Fe in the water; Se supplemented and Fe-deficient (+Se-Fe)
animals were given only Se in the water; Se-deficient and Fe supplemented (-Se+Fe)
animals given only Fe in the water. Selenium- and Fe-deficient animals (-Fe-Se) given
the deionized water free of both elements. All the animals were fed the above diet for 20
days prior to sacrifice.
Experiment four
For three months, rats (70-90g) were fed a semi-synthetic Fe- and Se-deficient
diet with an Fe and Se content of 15 ppm and less than 0.05 ppm, respectively, or a
carbonyl iron diet (Table 2). Animals were randomized into six dietary groups of ten
animals each: Se and Fe supplemented animals (+Se+Fe) given Se and Fe in water.
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Selenium supplemented and Fe-deficient animals (+Se-Fe) given Se only in the water. Sedeficient and Fe supplemented animals (-Se+Fe) given only Fe in the water. Iron- and Sedeficient animals (-Se-Fe) given deionized water only.

Iron overloaded and Se

supplemented animals (+Se++Fe) were fed the carbonyl iron diet and given Fe and Se in
water as described above. Iron overloaded and Se-deficient animals (-Se++Fe) were fed
the carbonyl iron diet and given Fe only in the water. Four hours before sacrifice 5.00 J..Ll
CBrCl3 (9.9 mM/ml/kg b.w., dissolved in 0.5 ml mineral oil) were given by gavage to
five animals from each of the four dietary groups (+Se+Fe, +Se-Fe, -Se+Fe, -Se-Fe).
The remaining five animals in each group were designated as control groups.
SAMPLE PREPARATION AND ANALYSES
Homogenates preparation
Rats were decapitated and exsanguined and the livers dissected and placed in
isotonic KCl. The intestinal tract was excised from the stomach at the pyloric junction and
gently pulled away from the mesentery. A 30 em section of small intestine was taken
beginning at the pyloric junction and placed in isotonic KCl. A 2 em section was also
taken starting at the point where the first section ended. Both sections were flushed with
30 and 10 ml of isotonic KCl, respectively, to wash out the intestinal contents. The 30 em
section was split longitudinally along the mesenteric axis. Excess liquid was removed
with ashless paper tissue and the epithelial mucosa gently scraped with the edge of a metal
spatula. The mucosal scrapes were weighed and homogenized in 3 volumes of KCl tris
buffer (150/25 mM) pH 7.5, with five strokes at full speed of a bio-homogenizer
(Bioespec Products, Inc., model M 133/1281-0). A very similar procedure has been
previously reported (Pascoe et al., 1983; Craven and DeRubertis, 1980). The intact 2 em
intestinal sections were similarly homogenized. The livers were blotted dry on filter paper
and weighed. Liver homogenates were prepared in 2 volumes of KCl tris buffer (150/25
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mM) pH 7.5 with a Polytron tissue homogenizer (Brinkmann Industries, model PT
45/80) with five strokes at intermediate (5) intensity speed. All the procedures were
conducted in a cold-room at 4 °C. A 1 ml homogenate aliquot of each tissue was wet
-ashed, described below, and a 0.3 ml homogenate aliquot was frozen in liquid nitrogen
and stored at -70°C for future protein content determination. Following the same
procedure, a 5 mlliver homogenate aliquot was stored for cytochrome P-450 assay. The
remaining homogenates were centrifuged at 10,000 G and 4 °C for 10 minutes in an
International Equipment Company centrifuge, model HR-1. The 10,000 G supernatants
(lOS), were placed in 2 ml store vials, frozen in liquid nitrogen and stored at -70°C for
further assays.
Analytical procedures
Iron was determined in 1 ml of whole homogenates of liver, gastrointestinal
mucosa and intestinal rings after wet-ashing with HN03 and H202 to dryness and then
diluted to the appropriate volume with hydrochloric acid. Serum diluted with deionized
water was also analyzed for Fe. Iron was quantified spectrophotometrically, using
ferrozine color reagent (Stookey, 1970; see Appendix A for details). Samples were
assayed in triplicate. Precision for the triplicates was .43 ±.77 (mean ±standard
deviation) j.lg Fe/ml homogenate.
Se-dependent GSHPx activity was measured in the diluted liver and intestinal
supernatants, using H202 substrate. GSHPx activity in human blood was also measured
and its value compared with the stablished standard, to validate the assay (Paglia and
Valentine, 1967; see Appendix B for details). Samples were assayed in duplicate.
Precision for the duplicates was .004 ±.015 (mean ±standard deviation) j.!M
NADP/min/ml cytosol.
Lipid peroxidation in liver and intestinal supernatants was measured as
thiobarbituric acid reactive substances (TBARS ). Butylated hydroxytoluene was included
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in the assay mixture to prevent in vitro lipid peroxidation (Buege and Aust, 1984; see
Appendix C for details) . A set of assays of a same sample, were repeated over time to
evaluate possible TBARS generation during sample storage. No increased supernatent
TBARS level occurred during storage. See Appendix C. Samples were assayed in .
triplicate. Precision for the triplicates was .88 ±6.82 (mean ±standard deviation) nM
TBARS/ml cytosol. Cytochrome P-450 activity was assayed in liver homogenates, using
0-ethyl 0-(4-nitrophenyl) phenylphosphonothioate (EPN) and para-nitroanisol as
substrates (Kinoshita et al., 1966; see Appendix D for details). Samples were assayed in
triplicate. Precision for the triplicates was 4.78 ±5.26 (mean ±standard deviation) ~g paranitrophenol/h/ml homogenate.
Protein content of all the homogenate and supernatant samples was determined by
the binding of Coomassie Brilliant Blue G-250 to protein. Bovine serum albumin was
used as a reference material (Bradford, 1976; see Appendix F for details). Samples were
assayed in triplicate.

Precision for the triplicates was .15 ±.42 (mean ±standard

deviation) ml cytosol. A blood sample was taken from the rat's orbital venous capillary
bed just before decapitation. Hemoglobin in blood was determined spectrophotometricaly
as cyanomethemoglobin (Crosby et al. , 1954; see Appendix E for details).
Statistical analysis
Data were analyzed statistically by two-factor analysis of variance and randomized
complete block design. Orthogonal contrasts were used as tests of significance (Dowdy
and Wearden, 1983).
In experiment three data were analyzed statistically by two-way analysis of
variance and by analysis of variance for a randomized complete block design. When
applicable, statistical significance was determined by Fisher's least significant difference
test (LSD) (Dowdy and Wearden, 1983).
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CHAPTER IV

RESULTS AND DISCUSSION
EXPERIMENT ONE

Iron and selenium rats status
As shown in Table 3 and Appendix G, Table 18, the animals' weights were
significantly lower in all groups injected with iron dextran, while Se deficiency or Sesupplementation did not alter the rats' weights in any of the treatment groups.
Bromotrichloromethane did not affect the animal weights at either of the two doses. Thus,
the dose of iron dextran injected was probably toxic for the animals, and the trace amount
of Se present in the Se-deficient diet was sufficient to prevent the development of critical
Se deficiency in the rats. It is also probable that the Se body stores of these rats were
adequate to prevent Se deficiency during the short time of the experimentation. The dose
of Se supplemented in the water was not toxic to the animals. The lack of effect of the
CBrCl3 indicates that no obvious systemic toxic effect was induced by the halomethane.
Hemoglobin values were not significantly different among treatments (Table 3 and
Appendix G, Table 18) which is consistent with the regulation of red blood cell
production by the tissue oxygenation needs rather than by the excess of Fe (Harris and
Kellermeyer, 1974). Serum Fe values were significantly higher in all the groups injected
with iron dextran (Table 3 and Appendix G, Table 18). High serum Fe values are
generally associated with increased release of Fe from body stores, a condition seen in
hemochromatosis (Harris and Kellermeyer, 1974). As shown in Table 4 and Appendix
G, Table 19, total Fe was significantly higher in the livers (24x), the intestinal mucosa
(2x), and the whole intestines (7x) of animals injected with iron dextran as compared with
the control groups. Decreased levels of Fe-binding protein are consistently associated with
Fe overload, but there is evidence that Fe not bound to its specific transporter is deposited
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Table 3--Weight, hemoglobin, and serum iron in rats fed a torula yeast diet deficient in
selenium and injected with iron dextran.
Dietary treatments
Measures

+Se+Fe

-Se+Fe ·

+Se++Fe

-Se++Fe

CBrCl3a

253 ±17a
244 ±16
230 ±23

237 ±17a
247 ±20
242±9

198 ±20b
210 ±18
203 ±35

208 ±22b
218 ±11
209 ±31

Control
Dose!
Dose II

15 ±3a
17 ±1
15 ±1

16 ±1a
16 ±1
14 ±4

15 ±3a
14 ±4
16 ±3

16±3a
17 ±3
15 ±4

Control
Dose!
Dose II

3.9 ±l.Oa
3.7 ±1.0
4.0 ±0.9

3.8 ±0.7a
4.2 ±0.7
3.7 ±0.9

7.9 ±0.9b
7.6 ±1.2
9.2 ±2.2

8.4 ±1.3b
9.0 ±2.0
9.0 ±2.8

Control
Dose!
Dose II

Body weight, g
f1 (13.55)
f2 ( 0.87)
f3 ( 0.58)

Hemoglobin, g/dl
f1 ( 0.33)
f2 ( 0.66)
f3 ( 0.70)

Serum Fe, J.lg/ml
f1 (50.40)
f2 ( 0.61)
f3 ( 0.58)

acBrC13 (9.9 mM/ml). Dose I: 0.05J.ll/kg/day. Dose II: 0.5 J.ll/kg/day. Data are means
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values
(Alpha = 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) =
2.3. If any calculated f is higher than the respective table f value, there is a significant
difference between the compared factors. Orthorgonal comparisons as tests of main
effects: Values in the same row with the same superscript letter are not significantly
different. See Appendix G, Table 18.
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Table 4- Total iron (IJ.g Fe/mg protein) in intestinal mucosa, whole intestine, and livers of
rats fed a torula yeast diet deficient in selenium and injected with iron dextran

Dietary treatments
Tissues

+Se+Fe

-Se+Fe

+Se++Fe

-Se++Fe

2.0 ±0.4a
1.9 ±0.1
2.1 ±0.8

1.7 ±0.6a
1.5 ±0.1
1.4 ±0.02

4.1 ±0.4b
3.2 ±1.4
3.6 ±0.8

3.3 ±0.9b
4.6 ±2.2
3.6 ±1.3

Control .
Dose I
Dose II

2.5 ±1.2a
2.2 ±0.8
2.6 ±0.9

2.0 ±0.6a
2.2 ±0.8
2.2 ±0.7

17.9 ±3.8b
14.3 ±4.4
15.5 ±0.9

15.9 ±5.5b
16.0 ±5.4
16.6 ±6.2

Control
Dose I
Dose II

1.4 ±0.2a
1.3 ±0.2
1.3 ±0.2

1.4 ±0.2a
1.3 ±0.2
1.5 ±0.4

35.6 ±7.4b
29.9 ±7.9
29.6 ±7.1

31.4 ±5.0b
32.4 ±7.3
34.0 ±7.5

Control
Dose I
Dose II

Intestinal mucosa
f1 ( 21)
f2 (0.1)
f3 (1.1)

Whole intestine
f1 (71)
f1 (0.3)
f2 (0.3)

Liver
f1 (187)
f2 (0.5)
f3 (0.5)

--------------------------------------------------------------------------------------------------------acBrC13 (9.9 mM/ml). Dose I: 0.051J.l/kg/day. Dose II: 0.5 IJ.l/kg/day. Data are means
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values
(Alpha= 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) =
2.3. If any calculated f is higher than the respective table f value, there is a significant
difference between the compared factors. Orthorgonal comparisons as tests of main
effects: Values in the same row with the same superscript letter are not significantly
different. See Appendix G, Table 19.
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in practically all body areas, especially in spleen and liver. It has also been documented
that in the absence of Fe-binding protein, a greater than normal absorption of Fe from the
intestinal tract takes place. Studies in man indicate that in the presence of increased
saturations of Fe-binding protein, Fe continues to be transported across the intestinal
epithelial cell and delivered to the plasma (Harris and Kellermeyer, 1974). Se-dependent
GSHPx activity, an indirect parameter of Se status (Smith et al., 1974; Hafeman et al.,
1974), was significantly depressed in the livers (Table 5 and Appendix G, Table 20) and
intestinal mucosa (Table 6 and Appendix G, Table 21) of the groups fed theSe-deficient
diet as compared with controls. This indicates a response to the Se-deficient diet fed
during the 20 days of treatment. Since Se is an integral part of this peroxidase (Rotruck et
al., 1973; Flohe et al., 1973), this result is in agreement with the reported dependence of

the enzyme on Se for its activity (Smith et al., 1974; Hafeman et al., 1974).
Decreased Se-dependent GSHPx activity in the livers of lambs and rats with orally
induced Fe overload has been reported (Reffet et al., 1986; Lee et al., 1981). However,
the injected iron dextran did not induce any significant change in hepatic or intestinal Sedependent GSHPx activity in this study. A more chronic administration of Fe may be a
requirement for the modification of GSHPx activity. Reffet et al. (1986) and Lee et al.
(1981) induced dietary Fe overload over periods of 2.5 and 3.0 months respectively.
Induction of Se-dependent GSHPx activity in rats due to peroxidative stress
caused by ozone exposure (Chow and Tappe!, 1972), deficiency of vitamin E (Chow et
al., 1973), and dietary autoxidized lipids (Reddy and Tappel, 1974) has been reported.
By contrast, decreased GSHPx activity has been observed in the livers of rats treated with
2,3,7 ,8-tetrachlorodibenzo-p-dioxin (TCDD), a chemical that induces lipid peroxidation
(Hassan et al., 1985). The present results indicate that CBrCI3 does not induce a
significant change in the peroxidase activity. Thus, the observed change in Se-dependent
GSHPx activity was due solely to the Se-deficient diet.
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Table 5--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS
production in the livers of rats fed a torula yeast diet deficient in selenium and injected
with iron dextran
Dietary treatments
Measures
GSHPx,
f 1 (116)
f2 (0.9)

f3 ( 1.8)

~M

+Se+Fe

-Se+Fe

+Se++Fe

-Se++Fe

CBrCl3a

0.54 ±0.07a
0.62 ±0.08
0.55 ±0.07

0.20 ±0.06b Control
0.18 ±0.04 Dose I
0.18 ±0.06 Dose II

1.43 ±0.13abc 1.21 ±0.12b
1.35 ±0.19
1.52 ±0.37
1.49 ±0.18
1.35 ±0.20

1.40 ±0.20c Control
1.27 ±0.23 Dose I
1.34 ±0.12 Dose II

NADP/min/mg protein
0.59 ±0.12a
0.52 ±0.11
0.46 ±0.04

0.18 ±0.06b
0.18 ±0.06
0.22 ±0.09

P-450, ~g para-nitrophenol/hr/mg protein
Substrate: para-nitroanisol
f1 (3.1)
f2 (0.3)

f3 (1.3)

1.56 ±0.16a
1.47 ±0.09
1.61 ±0.28

P-450, ~g para-nitrophenol/hr/mg protein
Substrate: EPNb

f1 (1.5)
f2 (0.6)
f3 (0.6)

1.70 ±0.09a
1.55 ±0.06
1.59 ±0.27

1.61 ±0.12a
1.61 ±0.13
1.68 ±0.43

1.45 ±0.25a
1.50 ±0.44
1.54 ±0.33

1.46 ±0.22a Control
1.33 ±0.12 Dose I
1.61 ±0.24 Dose II

20±7a
20 ±1
20±4

64 ±16b
81 ±36
64±10

72 ±23b
74±32
102 ±49

TBARS, nM/100 mg protein
f1 ( 32)
f2 (0.4)

f3 (1.1)

24±3a
20±7
21 ±5

Control
Dose I
Dose II

aCBrC13 (9.9 mM/ml). Dose I: 0.05~1/k:g/day. Dose II: 0.5 ~1/k:g/day. Data are means
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values
(Alpha = 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) =
2.3. If any calculated f is higher than the respective table f value, there is a significant
difference between the compared factors. Onhorgonal comparisons as tests of main
effects: Values in the same row with the same superscript letter are not significantly
different. See Appendix G, Table 20.
bEPN: 0-ethyl-0-(4-nitrophenyl) phenylphosphonothioate.
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Table 6--Glutathione peroxidase (GSHPx) activity and TBARS production in the intestinal
mucosa of rats fed a torula yeast diet deficient in selenium and injected with iron dextran
Dietary treatments
Measures

+Se+Fe

+Se++Fe

-Se++Fe

0.05 ±0.01b
0.04 ±0.01
0.04 ±0.01

0.07 ±0.01ac
0.07 ±0.01
0.07 ±0.01

0.04 ±0.0 1b Control
0.04 ±0.01 Dose I
0.05 ±0.01 Dose II

81 ±27a
86 ±12
85 ±23

102 ±30b
118 ±32
151 ±48

115 ±26b
100 ±26
178 ±54

-Se+Fe

CBrCl3a

GSHPx, J.lM NADP/min/mg protein
f1 ( 31)

f2 (0.1)
f3 (0.9)

0.06 ±O.Ola
0.07 ±0.02
0.07 ±0.01

TBARS, nM/100 mg protein
f1 (13.3)
f2 ( 5.7)
f3 ( 2.2)

78 ±23a
62±16
73 ±24

Control
Dose I
Dose II*

aCBrC13 (9.9 mM/ml). Dose I: 0.05J.ll/kg/day. Dose II: 0.5 J.ll/kg/day. Data are means
±standard deviation for each treatment group; n = 5 rats in all groups. Table f values
(Alpha= 0.05). Diet: f1 (3,48) = 2.8. Dose: f2 (2,48) = 3.2. Interaction: f3 (6,48) =
2.3. If any calculated f is higher than the respective table f value, there is a significant
difference between the compared factors. Orthorgonal comparisons as tests of main
effects: Values in the same row with the same superscript letter are not significantly
different. The asterisk (*) means that dose II was significantly different from control and
dose I. See Appendix G, Table 20.
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A combined condition of lowered GSHPx activity and Fe overload in hepatic and
intestinal tissues was induced in the animals fed the Se-deficienrdiet and injected with iron
dextran (Tables 5 and 6 and Appendix G, Tables 20 and 21).
Cytochrome P-450 activity
As shown in Table 5 and Appendix G, Table 20, cytochrome P-450 activity in
liver homogenates was not significantly affected among treatment groups when EPN was
used as a substrate. The activity of the enzyme assayed with the substrate para-nitroanisol
was significantly lowered in the animals injected with iron dextran. However, this effect
was marginal (p < 0.037). Higher doses of injected Fe may be required to inhibit the
activity of cytochrome P-450 (Bacon et al., 1986). Cytochrome P-450 is required for the
activation of CBrCl3 by the liver (Recknagel and Glende, 1973). It can be assumed that
the present experimental conditions did not interfere with the activation of the halomethane
by the cytochrome P-450 enzyme system.
Lipid peroxidation
Lipid peroxidation measured as TBARS production was significantly higher in the
livers (Table 5 and Appendix G, Table 20) and the intestinal mucosa (Table 6 and
Appendix G, Table 21) of all the iron dextran injected animals as compared with controls.
This is in accordance with reports of in vivo enhanced lipid peroxidation in the liver. In
those reports, acute Fe overload was induced with intraperitoneal injected iron dextran at a
dose of 125 mg Fe/kg or 500 mg Fe/kg and measured as TBARS and ethane production,
respectively (Britton et al., 1987). Similar information for the intestinal mucosa is not
available. The Se-deficient animals did not show any significant differences in hepatic or
intestinal mucosa TBARS production as compared with controls. Thus, the lowered
hepatic and intestinal Se-dependent GSHPx activities observed in those animals did not
induce a higher susceptibility to lipid peroxidation in either tissue evaluated. It might be
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that under Se deficiency the hepatic Se-independent GSHPx was induced (Lawrence and
Burk, 1976) protecting the liver against lipid peroxidation. However, since there is noSeindependent GSHPx activity in the intestinal mucosa (Levander, 1982), this is not a
feasible explanation for the observed lack of increased intestinal lipid peroxidation in the
Se-deficient rats. Some of the reported rates of decrease of Se-dependent GSHPx activity
due to dietary Se deficiency (Nalini et al., 1976; Reddy and Tappel, 1974) are much more
lower than those reported for the liver enzyme (Hill and Burk, 1982) under similar
conditions. A diet with a lower Se content fed for a longer period of time might be
required in order to observe higher lipid peroxidation in both tissues.
The exposure to CBrCl3 did not significantly affect hepatic lipid peroxidation in
any of the treatment groups. However, a significantly higher lipid peroxidative activity
was observed in the intestinal mucosa of the groups exposed to the higher dose of CBrCl3
as compared with controls. A further analysis of the data (randomized block design,
Table 7) for the effect of CBrCl3 in each diet showed a significantly higher lipid
peroxidation in theSe-deficient and Fe overloaded group (-Se++Fe) of animals. This is
the group potentially most susceptible to lipid peroxidation due to the excess of Fe
available for the catalysis of lipid peroxidation and also due to the lower activity of
GSHPx for defense against it. It is known that Se deficiency and the consequent decrease
on Se-dependent GSHPx activity augmentates the hepatic toxicity of lipid peroxidation
initiated by Fe overload (Dougherty et al., 1981 ); but no similar information has been
reported for the intestinal mucosa. However, the intestinal mucosa is a tissue of high
potential susceptibility to dietary Se deficiency, due to its dependence on intraluminal
sources of the metal (Pascoe et al., 1983) and its lack of Se-independent GSHPx
(Levander, 1982).

The results are also in agreement with the previous finding that

CBrCl3 can stimulate lipid peroxidation in gastrointestinal tissue slices (Fraga et al.,
1987). To explain any further the observed higher susceptibility of the intestinal mucosa
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Table ?--Intestinal TBARS production data (Table 6) analyzed by randomized complete
block design for bromotrichloromethane dose in each diet
Diet

Error
(MSE)

Calculated f

+Se+Fe

0.05

0.70

-Se+Fe

0.05

0.06

+Se++Fe

0.15

2.16

-Se++Fe

0. 15

5.72

Table fvalue (Alpha= 0.05); Dose f (2,12) = 3.9. If any calculated fis higher than the
table f value, there is a significant difference between the compared factors.
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to lipid peroxidation associated with the intake of CBrCl3 as compared with that of the
liver, we have to speculate. It could be that the liver Se-independent GSHPx enzyme
activity was induced offering protection against lipid peroxidation. It could also be that
CBrCl3 reached the intestinal mucosa in a more concentrated dose than that carried by the
portal circulation from the intestine to the liver, favoring a higher response in the intestinal
mucosa. In this case, we are also assuming that the activation of CBrCl3 took place in the
intestinal tract where the free radicals formed were immediately available for the induction
of lipid peroxidation in spite of their extremely short life. However, we do not know if
the observed increase in lipid peroxidation was directly caused by the free radicals formed
or as a consequence of some other effect induced by the activated halomethane.

EXPERIMENT TWO

Iron and selenium status
As shown in Table 8 and Appendix G, Table 22, the body weights of the rats fed
the 2% carbonyl iron diet were significantly lower than control rats fed normal dietary Fe
levels. The Se-deficient diets and the Se supplementation in water did not affect animal
weights. The trace amount of Se present in the Se-deficient diet was probably enough to
prevent the development of critical Se-deficiencieny in the rats, and the dose of Se
administered in water was probably not toxic to the animals. On the other hand, the
ingestion of carbonyl iron probably reached toxic levels in the animals fed high-Fe diet
because blood was observed in the animals' feces during the last weeks of the trial.
Hemoglobin values were significantly lower in the animals with the combined
condition of Fe overload and Se deficiency (-Se++Fe) as compared with controls (Table 8
and Appendix G, Table 22);

however, the effect was marginal (p<0.048).

Low

hemoglobin and hematocrit values have been reported under orally induced Fe overload
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Table 8--Weight, hemoglobin, and serum iron in rats fed a 2% carbonyl iron diet deficient
in selenium and gavaged with bromotrichloromethane.
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se++Fe

-Se++Fe

---------------------------------------------------------------------------------------------------------Weight, g
f1 (101)
f2 (1.9)

281 ±lOa
263 ±8

287 ±26a
271 ±10

153 ±20b
137 ±16

122 ±13b
128 ±25

Control
Dose

13 ±2a
13 ±1

13 ±la
14 ±2

12 ±5ab
10 ±1

11 ±5b
6 ±1

Control
Dose

2.5 ±o.5a
2.7 ±1.0

3.0 ±0.7a
3.0 ±0.6

3.1 ±0.2a
2.7 ±1.2

3.8 ±0.4a
1.9 ±0.6

Control
Dose

f3 (0.5)
Hemoglobin, g/dl
f1 (3.3)
f2 (1.5)

f3 (1.4)
Serum Fe, 11-g/ml
f1 (0.2)
f2 (2.3)

f3 (1.5)
aCBrC13 (9.9 mM/ml). Dose: 5.0!11/kg/day. Data are means ±standard deviation for each
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) =
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is
higher than the respective table f value, there is a significant difference between the
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same
row with the same superscript letter are not significantly different. See Appendix G,
Table 22.
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combined with vitamin E and Se deficiency (Lee et al., 1981). A further statistical
analysis of the data (Table 12) for the effect of CBrCl3 in each diet showed a significantly
lower hemoglobin value in the -Se++Fe group, but this effect was also marginal (P <
0.032). Bromotrichloromethane may have increased red cell hemolysis in the liver which
may have been affected by the combined condition of Fe overload and Se deficiency
suggested by the higher lipid peroxidation activity observed in this treatment group (Table
10 and Appendix G, Table 24). Some animals in this group had bloody feces which may
have accounted, in part, for the lowered hemoglobin values. Serum Fe values were not
significantly different among treatments for either diet or CBrCl3 when the data were
statistically analyzed by two-factor analysis of variance (Table 8 and Appendix G, Table
20). A further statistical analysis of the data by randomized complete block design for the
effect of CBrCl3 in each diet (Table 12) showed a significantly lowered serum Fe value in
the -Se++Fe group. Since those animals had significantly higher levels of Fe in all the
tissues analyzed, as described below, the possibility of Fe deficiency can be discarded. A
more feasible explanation lies on the blood loss experienced by some animals in this group
and also on the possibility that these animals were using serum Fe for the synthesis of
new hemoglobin. Herbert (1975) reports a greatly reduced plasma Fe level during
remission of hemolytic anemia, similar to the reduction observed in Fe deficiency.
As shown in Table 9 and Appendix G, Table 23, liver Fe values were significantly
higher in the Fe overloaded groups (13x) as compared with the normal Fe groups. Liver
Fe in the -Se++Fe group was significantly, but marginally (p < 0.019), higher than in the
+Se++Fe group. Further statistical analysis (Table 12) did not ·show any significant
differences among treatments for liver Fe values.
Intestinal mucosa (4x) and whole intestine (3x) Fe levels were also significantly
higher in the Fe overloaded rats as compared with the normal Fe rats (Table 9 and
Appendix G, Table 23).
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Table 9--Iron (J...Lg Fe/mg protein) in livers, intestinal mucosa, and whole intestines of rats
fed a 2% carbonyl iron diet deficient in selenium and gavaged with
bromotrichloromethane.
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se++Fe

-Se++Fe

----------------------------------------~-----------------------------------------------------------------

Liver
f1 (48.7)
f2 ( 0.3)
f3 ( 0.1)

1.2 ±0.3a
1.6 ±0.4

1.5 ±0.1a
1.4 ±0.1

15.5 ±2.9b 20.0 ±7.7C
16.2 ±2.0 22.1 ±3.1

Control
Dose

1.9 ±0.2a
2.0 ±0.3

2.0 ±0.4a
2.2 ±0.4

6.5 ±0.5b
6.5 ±0.6

7.1 ±0.9b
8.1 ±1.7

Control
Dose

2.6 ±0.5a
2.6 ±0.5

2.6 ±0.5a
2.1 ±0.5

7.2 ±0.3b
7.8 ±0.3

7.2 ±0.6b
7.4 ±0.8

Control
Dose

Intestinal mucosa
f1 (67.4)
f2 ( 0.8)
f3 ( 0.4)
Whole intestine
f1 (129)
f2 (0.1)
f3 (0.7)

aCBrC13 (9.9 mM/ml). Dose: 5.0J...Ll/kg/day. Data are means ±standard deviation for each
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) =
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is
higher than the respective table f value, there is a significant difference between the
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same
row with the same superscript letter are not significantly different. See Appendix G,
Table 23.
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Selenium-dependent GSHPx activity was significantly lower in livers (Table 10
and Appendix G, Table 24) and intestinal mucosa (Table 11 and Appendix G, Table 25)
of the groups fed the Se-deficient diet as compared with controls. This indicates a
response to theSe-deficient diet (Smith et al., 1974; Hafeman et al., 1974); a similar
observation was reported in experiment one. Hepatic Se-dependent GSHPx activity was
significantly lower in the +Se++Fe group as compared with the +Se+Fe group (Table 10
and Appendix G, Table 24) indicating a possible effect of Fe overload on the enzyme
activity. This is in agreement with similar findings in livers of chronically Fe overloaded
rats and lambs (Lee et al., 1981; Reffet et al., 1986). A similar effect was also observed
in the intestinal mucosa of the same group of animals (Table 11 and Appendix G, Table
25).
In experiment one, the induced acute Fe overload resulted in a higher liver Fe
concentration (24x) than the one chronically induced in this experiment (17x). However,
no effect over the Se-dependent GSHPx activity in liver was observed. It could be that a
slow and sustained build up of chronic Fe overload over time is required to observe
lowered Se-dependent GSHPx activity. Since animals were 80g anhe beginning of this
experiment as compared with 220g in experiment one, the age factor cannot be excluded.
Carbonyl iron induces in rats a homogeneous distribution of Fe (in hepatocytes),
analogous to that distribution seen in human hereditary hemochromatosis. A more
heterogeneous deposition (in hepatocytes and Kupffer cells) has been observed in Fe
overload induced parenterally (Bacon et al., 1986). It is possible that a lower intestinal
and hepatic Se-depedent GSHPx activity accompanies Fe overload in human
hemochromatosis causing a higher susceptibility toward lipid peroxidation and its negative
effects in human health. More research is needed to further elucidate this possibility.
A possible explanation for the observed lower Se-dependent GSHPx activity in
rats with induced Fe overload is the presence of cysteine and histidine residues at the
enzyme's active site (Combs and Combs, 1986). These aminoacids are highly susceptible
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Table 10--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS
production in the livers of rats fed a 2% carbonyl iron diet deficient in selenium and
gavaged with bromotrichloromethane.
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se++Fe

.

-Se++Fe

GSHPx, J.J.M NADP/min/mg protein
f1 (118)
f2 (0.84)
f3 (3.22)

0.77 ±0.04a 0.07 ±0.01b 0.72 ±0.03c 0.05 ±0.03bd Control
0.84 ±0.09 0.09 ±0.01 0.50 ±0.06 0.04 ±0.03
Dose

P-450, J.J.g para-nitrophenol/hr/mg protein
Substrate: para-nitroanisol
f1 (0.57)
f2 (0.04)
f3 (0.32)
Substrate: EPNb

1.63 ±0.32a 1.48 ±0.17a 1.70 ±0.33a 1.73 ±0.22a
1.48 ±0.21 1.68 ±0.41 1.68 ±0.23 1.8 ±0.23

Control
Dose

f1 (0.62
f2 (0.04)
f3 (0.82)

1.80 ±0.34a 1.60 ±0.15a 1.79 ±0.37a 1.99 ±0.22a
1.50 ±0.26 1.88 ±0.47 1.86 ±0.14 1.83 ±0.16

Control
Dose

TBARS, nM/100 mg protein
f1 (75.4)
f2 (1.68)
f3 (0.92)

19±3a
21 ±5

20±4a
21 ±4

112±19b
118 ±27

144±22C
178 ±21

Control
Dose

aCBrC13 (9.9 mM/ml). Dose: 5.0J.J.l/kg/day. Data are means ±standard deviation for each
treatment group; n =5 rats in all groups. Table f values (alpha =0.05). Diet: f1 (3, 16) =
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is
higher than the respective table f value, there is a significant difference between the
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same
row with the same superscript letter are not significantly different. See Appendix G,
Table 24.
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Table 11--Glutathione peroxidase activity (GSHPx) and TBARS production in the
intestinal mucosa of rats fed a 2% carbonyl iron diet deficient in selenium and gavaged
with bromotrichloromethane.
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se++Fe

-Se++Fe

GSHPx, J.!M NADP/min/mg protein
f1 (23.1)
f2(0.1)
f3 ( 0.1)

0.08 ±0.01a 0.04 ±0.01b 0.06 ±O.OOc 0.02 ±0.01b
0.08 ±0.02 0.03 ±0.01 0.06 ±0.01 0.02 ±0.00

Control
Dose

TBARS, nM/100 mg protein
f1 (12.6)
f2 ( 5.0)
f3 ( 2.6)

125 ±26a
151 ±34

153 ±27a
150 ±23

205 ±36b
235 ±45

252 ±55c
438 ±84·

Control
Dose*

aCBrC13 (9.9 mM/ml). Dose: 5.0Jll/k:g/day. Data are means ±standard deviation for each
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) =
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is
higher than the respective table f value, there is a significant difference between the
compared factors. Orthorgonal comparisons as tests of main effects: Values in the same
row with the same superscript letter are not significantly different. The asterisk (*) means
that the CBrCl3 dose effect was significantly different from control. See Appendix G,
Table 25.
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Table 12--Hemoglobin, serum, and liver iron and liver and intestinal mucosa TBARS data
(Tables 8, 9, 10 and 11) analyzed by randomized complete block design for
bromotrichloro-methane dose in each diet
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se++Fe

-Se++Fe

Parameters

----------------------------------------------------------------------------------------------------------

Hemoglobin

0.24
1.68

3.16
1.34

1.40
11.52

6.89
11.21

Calculated f
Errora

0.04
0.66

0.03
0.38

0.59
0.69

33.09
0.27

Calculated f
Error

2.95
0.10

1.56
0.01

0.23
6.05

0.34
34.60

Calculated f
Error

0.36
0.00

0.12
0.00

0.15
0.06

5.75
0.05

Calculated f
Error

Intestinal mucosa TBARS
1.94
0.09

0.03
0.07

1.32
0.17

20.40
0.42

Calculated f
Error

Serum Fe

Liver Fe

LiverTBARS

aError line entries are MSE.
Table f value (alpha = 0.05)
Dose: f (1,8) = 5.32
If any calculated f is higher than the table f value, there is a significant difference between
the compared factors.
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to lipid peroxidation leading to the inactivation of a number of enzymes (Tappel, 1973).
Under Fe overload, lipid peroxidation could also affect other enzymes such
as glucose 6-phosphate dehydrogenase, a membrane bound enzyme essential for the
generation of NADPH which is used, in turn, for the generation of reduced glutathione
(Combs and Combs, 1986). Since GSHPx catalyzes the detoxication of hydrogen
peroxide by the oxidation of reduced glutathione (Paglia and Valentine, 1967), the
inactivation of glucose 6-phosphate dehydrogenase could indirectly limit the GSHPx
activity. However, this potential effect could not be measured with the Paglia and
Valentine method (1967) since NADPH is used in the reaction mixture as described
Appendix B. In future research the activity of glucose-6-phosphate dehydrogenase in rats
under acute and chronic Fe overload, as compared with that of controls, should be
measured.
As in experiment one, CBrCl3 did not induce any significant change in Sedependent GSHPx among treatments in either livers or intestinal mucosa.
Cytochrome P-450 activity
As shown in Table 10 and Appendix G, Table 24 the cytochrome P-450 activity
was not affected significantly among treatments with any of the two substrates assayed.
Accordingly, feeding a 2.5% carbonyl iron diet for a period of 10 weeks, Bacon et al.
(1986) did not find a difference in liver cytochrome P-450 activity either. Thus, no
interference with the required activation of CBrCl3 by the cytochrome P-450 (Recknagel
and Glende, 1973) is expected to have occurred in this study.
Lipid peroxidation
Lipid peroxidation, measured as TBARS production, was significantly higher in
the livers (Table 10 and Appendix G, Table 24) and the intestinal mucosa (Table 11 and
Appendix G, Table 25) of all the carbonyl iron overloaded animals as compared with
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controls. This is in accordance with reports of in vivo enhanced hepatic lipid peroxidation
due to similar Fe overload levels (Britton et al., 1987). There was also a significantly
higher TBARS production in the -Se++Fe group as compared with the +Se++Fe group in
both tissues. This is probably due to the drastically lowered Se-dependent GSHPx
activity induced during the two months of treatment. No significant difference in lipid
peroxidation was observed between the +Se+Fe and the -Se+Fe groups. The lower
GSHPx activity alone does not correlate with increased lipid peroxidation; the combined
condition of Fe overload and depressed GSHPx activity is required for a significant
generation of lipid peroxidation. The exposure to CBrCl3 did not significantly affect
hepatic lipid peroxidation (Table 10 and Appendix G, Table 24). However, further
statistical analysis (Table 12) indicates a marginally significant (P<0.045) hepatic effect of
the halomethane in the -Se++Fe group of animals. Also, as shown in Table 11 and
Appendix G, Table 25, CBrCl3 induced lipid peroxidation significantly (P<0.042) in the
intestinal mucosa as compared with controls. Further statistical analysis (Table 12)
showed a significant increase in lipid peroxidation, in the Se-deficient and Fe overloaded
group (-Se++Fe). This result is in agreement with the observation in experiment one, in
which rats with acute Fe overload and Se deficiency were also responsive to a lower dose
of CBrCl3.
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EXPERIMENT TIIREE

Iron and selenium status
As shown in Table 13, Fe content was significantly lower only in the intestinal
mucosa of the animals fed the Fe-deficient and Se-supplemented diet. A slightly lower
intestinal mucosa level of Fe was found in the rats fed the Fe-deficient or Se-deficient
diets. This is consistent with the reported dependence of this tissue on intraluminal Fe
(Pascoe et al., 1983).

No significant differences in liver Fe were detected among

treatments during the relatively short period of Fe deficiency. Liver iron seems to depend
on the whole body stores of the metal (Pascoe et al., 1983).

In accordance, the

hemoglobin values were not significantly different among the treatments (Table 13). Sedependent glutathione peroxidase (GSHPx) activity, an indirect parameter of the rat Se
status (Smith et al., 1974; Hafeman et al., 1974), was significantly lower in the liver and
intestinal mucosa of the two groups fed the Se-deficient diet as compared with the control
groups indicating a response to theSe-deficient diet fed during the 20-day trial (Table 13).
The combined deficiencies of Fe and Se did not add any effect to the observed differences
in total Fe or in GSHPx activity. Previous studies have demonstrated that, in tissues such
as human, rabbit, and rat erythrocytes and rat liver, Fe deficiency resulted in lower
GSHPx activities (MacDougall, 1972; Rodvien et al., 1974; Lee et al., 1981). However,
the present results indicate that, although significant differences in total Fe content in the
intestinal mucosa were observed in animals fed the Fe-deficient diet, Fe deficiency did not
affect intestinal mucosal GSHPx activity in either the Se supplemented or Se
unsupplemented animals (Table 13). A more drastic deficiency of Fe may be required to
induce such an effect on GSHPx activity.
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Table 13--Iron, glutathione peroxidase (GSHPx) activity, and TBARS production assayed
in the livers and small intestine mucosa, cytochrome P-450 activity in the livers, and
hemoglobin in blood of rats fed a diet deficient in iron and/or selenium for 20 days

Dietary treatments
Measures

-Se+Fe

+Se+Fe

+Se++Fe

-Se++Fe

---------------------------------------------------------------------------------------------------------Hemoglobin, g/dl

19 ±1.1

17 ±0.6

18 ±1.2

18 ±0.6

NS

Total iron, Jlg Fe/mg protein
Liver

1.52 ±0.54

2.13 ±0.46

1.74 ±0.65

1.93 ±0.38

NS

Mucosa

1.60 ±0.33

1.49 ±0.33

0.85 ±0.24

1.13 ±0.47

0.47

GSHPx, J.l.M NADP/min/mg protein
Liver

0.71 ±0.07

0.45 ±0.16

0.67 ±0.19

0.40 ±0.07

0.20

Mucosa

0.07 ±0.01

0.05 ±0.01

0.07 ±0.01

0.05 ±0.01

0.01

TBARS, nM/100 mg protein
Liver

8.28 ±1.38

12.4 ±3.30

7.95 ±1.80

16.34 ±2.55

3.18

Mucosa

61.9 ±15.4

114.7 ±32.3

75.4 ±18.9

114.8 ±24.9

31.9

1.24 ±0.47

2.14 ±0.83

1.38 ±0.52

NS

0.73 ±0.25

1.23 ±0.60

0.6 ±0.37

NS

P-450, j.lg Para-nitrophenol/hr/mg protein
Liver
Substrate: EPNb
1.36 ±0.28
Substrate: Para-nitroanisol
1.13 ±0.23

aData are means ±standard deviation for each treatment group; n = 5 in all groups.
Statistical significance was determined by Fishers's least significant difference test (LSD).
Mean differences must equal or exceed the LSD value to be significant at the 5%
probability level. NS, not statistically significant.
hEPN means 0-ethyl-0-(4-nitrophenyl) phenylphosphonothioate.
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Lipid peroxidation
Lipid peroxidation, measured as TBARS production, was significantly higher in
liver and intestinal mucosa of animals fed theSe-deficient diet (Table 13). These results
were not reproducible in subsequent experiments which may be due to the use of diets
with a higher content of Se (<0.05 ppm) in those experiments. Similarly, Reiter and
Wendel (1983), working with mouse liver, demonstrated that, in a very low Se
supplementation range (induced with a dietary Se content of <0.01 ppm), Se plays a
regulatory role on several hepatic enzymes other than GSHPx activity. However, using a
dietary Se content of 0.05 ppm, Reiter and Wendel (1984) failed to reproduce their
previous results. With the low Se content diet (0.0 1 ppm), they also observed a 30%
increase in arachidonic acid in the liver microsomes. It might be that, in spite of the
relatively short time of Se deficiency in this study, the low level of dietary Se fed to the
animals (<0.02 ppm) induced changes conducive to higher lipid peroxidation.
Cytochrome P-450 activity
Cytochrome P-450 activity assayed in liver homogenates did not show
significantly different values for any of the treatment groups when data were analyzed on a
randomized block design (Table 21). In contrast, when a two-way analysis of variance
was applied, the activity of the enzyme assayed with the substrate para-nitroanisol was
significantly lowered in the animals fed theSe-deficient diets. However, the effect was
marginal (p < 0.038). These results are in accordance with the reported resistance of liver
cytochrome P-450 to even acute deficiencies of Fe (Dallman and Goodman, 1971); as well
as the requirement of more drastic Se deficiencies in order to affect cytochrome P-450
activity (Burk and Correia, 1981).
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EXPERIMENT FOUR
Iron status
As shown in Table 14 and Appendix G, Table 26, animal weights were
significantly lower in all groups fed the 2% carbonyl iron diet. The dose of carbonyl iron
fed was probably toxic to the animals. These results are similar to those reponed in
experiment two after two months of feeding a similar carbonyl iron diet. Because the Seand/or Fe-deficient diets did not alter the rats' weights, the trace amounts of Se and Fe
present in the semi-synthetic diet were probably sufficient to prevent the development of
critical Se and/or Fe deficiency in the rats fed with it. Hemoglobin values were not
significantly different among any of the treatment groups (Table 14 and Appendix G,
Table 26), confirming the absence of severe Fe deficiency. However, as shown in Table
14 and Appendix G, Table 26, a trend of lowered total Fe content in liver and intestinal
mucosa was generally observed under the Fe-deficient treatments as compared with
controls. When an orthogonal comparison of (+Se+Fe & -Se+Fe) vs (+Se-Fe & -Se-Fe)
for main treatment combinations was made, liver Fe was found to be significantly lower in
the rats fed Fe-deficient diet. The high-Fe treatment resulted in a significantly higher Fe
content in all the tissues evaluated as compared with controls: Liver (9 x), intestinal
mucosa (4x), and whole intestines (3x) (Table 14 and Appendix G, Table 26). This is in
agreement with the described deposition of Fe associated with Fe overload in practically
all body areas, especially in spleen and liver, as described by Harris and Kellermeyer
(1974). Hemoglobin values (Table 14 and Appendix G, Table 26) were not significantly
different among Fe overloaded animals as compared with controls which is consistent
with the regulation of red blood cell production by the tissue oxygenation needs rather
than by the excess of Fe (Harris and Kellermeyer, 1974). Serum Fe was not evaluated in
the Fe overloaded animals, but in experiment two rats fed a similar carbonyl Fe diet during
2 months did not show a significant difference in serum Fe values among normal Fe
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Table 14--Weight, hemoglobin, and hepatic and intestinal iron in rats fed a diet deficient in
selenium and iron or fed a 2% carbonyl iron diet deficient in selenium
Dietary treatment
Measures

+Se+Fe

-Se+Fe

+Se-Fe

-Se-Fe

+Se++Fe

-Se++Fe

Weight, g
f (98.0)

357 ±21a

358 ±19a

364 ±22

351 ±29

192 ±15b

170 ±15b

15 ±2a

14 ±1a

13 ±1a

15 ±1a

15 ±2a

1.7 ±0.4a

1.6 ±0.2a

0.6 ±0.1

0.6 ±0.1

15.1 ±0.9b 14.9

Intestinal mucosa
f (113.0)
1.6 ±0.3a

1.4 ±0.2a

0.9 ±0.2

0.8 ±0.1 7.1 ±1.1b

6.0 ±0.8c

2.6 ±0.4a 2.6 ±0.4a

2.4 ±0.3

2.8 ±0.2 7.5 ±0.9b

7.2 ±1.3b

Hemoglobin, g/dl
15 ±2a
f (1.1)
Total iron, j..lg Fe/mg protein
Liver
f (329.5)
±1.9b

Whole intestine
f (60.2)

Data are means ±standard deviation for each treatment group; n = 5 rats in all groups.
Table f value (alpha 0.05): f (5,24) = 2.62. If any calculated f is higher than the table f
value, there is a significant difference between the compared factors. Values in the same
row with the same superscript letter are not significantly different based on orthogonal
comparisons. See Appendix G, Table 26.
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supplemented animals and Fe overloaded animals. However, rats with acute Fe overload
due to injections of Fe dextran had significantly higher values of serum Fe as compared
with controls (experiment one). The four dietary groups that received CBrCl3 did not
experience significant changes in hemoglobin or serum Fe among them due to the diet or
due to the CBrCl3 (Table 15 and Appendix G, Table 27). However, the orthogonal
comparisons for main treatment effects showed significantly lower hemoglobin and serum
Fe values in the Fe-deficient groups as compared with controls (Appendix G, Table 27).
Selenium status
Se-dependent GSHPx activity, an indirect parameter of Se status (Smith et al. ,
1974; Hafeman et al., 1974), was significantly depressed in liver and intestinal mucosa of
the groups fed theSe-deficient diet as compared with controls (Table 16 and Appendix G,
Table 28). This result is consistent with those described in experiments one, two and
three under different periods of induced Se-deficiency. Significantly decreased hepatic Sedependent GSHPx activity was found in the Fe overloaded and Se supplemented rats as
compared with controls (+Se+Fe vs +Se++Fe), (Table 15 and Appendix G, Table 28).
These results confirm those of experiment two also observed under chronic Fe overload.
They are in agreement with similar reports in lambs (Reffet et al., 1986) and rats (Lee et
al., 1981) with orally induced Fe overload. A significantly lowered activity of Sedependent GSHPx was also observed in the intestinal mucosa of the Fe overloaded rats as
compared with controls (+Se+Fe vs +Se++Fe). The lowered activity of the intestinal
peroxidase was also marginally significant in the Fe overloaded and Se-deficient animals
as compared with controls (-Se+Fe vs -Se++Fe) (Table 16 and Appendix G, Table 28).
In experiment two, a similar effect of chronic Fe overload over the hepatic and intestinal
Se-dependent GSHPx was observed. Acute Fe overload induced with Fe dextran
injections (experiment one) did not induce any changes on Se-dependent GSHPx.
Chronic induction of Fe overload seems to be required for the modification of GSHPx
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Table 15--Hemoglobin and serum iron in rats fed a diet deficient in selenium and /or iron
and gavaged with bromotrichloromethane
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se-Fe

-Se-Fe

15 ±1.7a
15 ±2.2

15 ±1.6a
16 ±0.7

14 ±o.sa
15 ±1.6

13 ±0.5b
13 ±0.9

Control
Dose

3.5 ±0.7a
3.3 ±0.5

3.0 ±0.4a
3.1 ±0.6

2.4 ±0.5b
2.8 ±0.6

2.7 ±0.3b
2.3 ±0.4

Control
Dose

Hemoglobin, g/dl
f1 (3.0)
f2 (0.4)

f3 (0.5)
Serum Fe, j..!g/ml
f1 (3.2)
f2 (0.01)

f3 (0.4)
acBrC13 (9.9 mM/ml). Dose: 5j..!l/kg. Data are means ±standard deviation for each
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) =
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is
higher than the respective table f value, there is a significant difference between the
compared factors. Values in the same row with the same superscript letter are not
significantly different based on orthogonal comparisons. See Appendix G, Table 27.
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activity in both, liver and intestinal mucosa. Since animals were 80g at the beginning of
this experiment as compared with 220g in the experiment in which acute Fe overload was
induced, the age factor cannot be excluded. Iron deficiency did not induce any significant
difference in Se-dependent GSHPx activity in the liver or intestinal mucosa of either Se
supplemented or Se unsupplemented animals (Table 16 and Appendix G, Table 28).
Previous studies have demonstrated that in tissues such as human, rabbit, and rat
erythrocytes and rat liver, Fe deficiency resulted in lower GSHPx activities (MacDougall,
1972; Rodvien et al., 1974; Lee et al., 1981). Again, a more drastic Fe deficiency may be
necessary to induce a significant change in the peroxidase activity.
Bromotrichloromethane did not have a significant effect on Se-dependent GSHPx
activity in liver or intestinal mucosa in any of the four groups of rats treated (Table 17 and
Appendix G, Table 29). This could be due to the fact that the animals were exposed just
once to the halomethane and killed four hours later not allowing enough exposure time to
the challenger for any significant change in the peroxidase activity to take place. In
experiment one, CBrCl3 gavaged to rats at a lower dose for five consecutive days until
sacrifice did not change significantly the Se-dependent GSHPx either.
Cytochrome P-450 activity
As shown in Table 16 and Appendix G, Table 28, liver cytochrome P-450 activity
assayed with the substrate, EPN, was not significantly different from the controls for any
of the dietary treatments. When assayed with para-nitroanisol, the changes on enzyme
activity were marginally significant for the dietary treatments. The orthogonal comparison
for main treatment effects between (+Se+Fe & +Se++Fe) vs (-Se+Fe & -Se++Fe) and(Se++Fe) vs (+Se ++Fe) showed a significantly lower cytochrome P-450 activity in theSedeficient groups as compared with the Se supplemented groups. There is evidence that in
severe Se deficiency there may be decreases in some forms of hepatic cytochrome P-450,
especially when inducers of the enzyme such as phenobarbital are administered to the rats.
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Table 16--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS
production in rats fed a 2% carbonyl iron semi-synthetic diet deficient in selenium.
Dietary treatment
Measures
GSHPx,

~M

+Se+Fe

-Se+Fe

+Se-Fe

-Se-Fe

+Se++Fe

-Se++Fe

NADP/min/mg protein

Liver
f (75.6) 0.73 ±.lOa
±.Qlac
Intestinal mucosa
f (25.2) 0.15 ±.02a

0.07 ±.Olb 0.78 ±.07 0.09 ±.Olb 0.47 ±.15b 0.01

0.05 ±.Olb 0.17 ±.06 0.05 ±.Olb 0.08 ±.02b 0.01 ±.ooc

P450, ~g Para-nitrophenol /hr/mg protein
Liver
Substrate: para-nitroanisol
f (2.7) 1.47 ±.30 1.32 ±.28
Substrate: EPNa
f (1.2) 1.79 ±.19a

1.57 ±.30

1.65 ±.22

1.67 ±.14a 1.24 ±. lib

1.69 ±.13a 1.78 ±.28a 1.83 ±.08a 1.83 ±.lOa

1.61 ±.19a

TBARS, nM/100 mg protein
Liver
f (54)

12±3a

Intestinal mucosa
f (18)
65 ±21a

13 ±2a

11 ±4

10±3

134 ±26b

246 ±66ac

69 ±2Ia

60±15

57 ±25

150 ±4b

197 ±40ac

aEPN: 0-ethyl 0-(4-nitrophenyl) phenylphosphonothioate.
Data are means ±standard deviation for each treatment group; n = 5 rats in all groups.
Table f value (alpha 0.05): f (5,24) = 2.62. If any calculated f is higher than the table f
value, there is a significant difference between the compared factors . Values in the same
row with the same superscript letter are not significantly different based on orthogonal
comparisons. See Appendix G, Table 28.
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Selenium seems to be required for the maintenance of one or more forms of cytochrome P450 (Burk and Correia, 1981). However, Reiter and Wendel (1983, 1984) did not
observe any significant change in the cytochrome P-450 activity assayed with aniline
(hydroxylation) or with aminopyrine (demethylation) after 2 and 6 months of low dietary
Se (0.01 ppm) treatment. They detected, instead, a 240% increase in the cytochrome P450 activity when assayed with 7-ethoxycoumarin (de-ethylation). These authors
observed that the 0.01 ppm dietary Se level was a requirement for the induction of the
enzyme; with a diet of 0.05 ppm Se, they failed to induce any statistically significant
changes. These reports indicate that the overall influence of Se on xenobiotic metabolism
is likely to be very complex.
Iron overload did not change significantly the cytochrome P-450 activity. This is
in agreement with Bacon et al. (1986) who did not observe a significant change in
cytochrome P-450 when feeding rats with a chow diet supplemented with 2% carbonyl
iron for 5 months. In experiments one and two, Fe overload did not induce any important
change in the cytochrome P-450 activity either. The lack of effect of the Fe-deficient diet
on the cytochrome P-450 activity (Table 16 and Appendix G, Table 28) is consistent with
the reported resistance of the cytochrome to acute deficiency of Fe (Dallman and
Goodman, 1971 ); even though Fe status affects the P-450 content in other rat tissues
(Dhur et al., 1989). Since the effect of Se deficiency on the cytochrome P-450 assayed
with para-nitroanisol is too small to affect meaningfully the activation of CBrCl3 by the
enzyme, no interference with the required activation of CBrCl3 by the liver cytochrome P450 (Recknagel and Glende, 1973) is expected. Due to the different nature of the
intestinal mucosa as compared with that of liver, the activation of CBrCl3 in the intestinal
tract might not depend on cytochrome P-450 as critically as in liver.
Not only the intestinal wall but also the intestinal microflora may transform
xenobiotics enzymatically (Vainio and Hietanen, 1980). The activation of several kinds of

62

xenobiotics, some of them procarcinogens, has also been reported to be associated with
cooxidation with prostaglandin synthase (PHS) during oxidation of arachidonic acid
(Ross, 1985). PHS activit)' is relatively high in many extra-hepatic tissues which are low
in mixed function oxictase, such as the intestinal mucosa. Thus, it has been proposed that
PHS could be an alternative or additional enzyme system for the metabolic activation of
compounds which exhibit extra-hepatic toxicity and carcinogenicity (Krauss and Eling,
1984; Ross, 1985). In the rat, the total intestinal cytochrome P-450 is about 1.6% of the
level in liver (0.1 vs 0.9 nmoVmg microsomal protein) (Vainio and Hietanen, 1980). It
has been suggested that intestinal enzyme activities observed in rats on noJ!Ilallaboratory
chow are due to exogenous factors in the diet which induce enzymes present at very low
levels (Wattenberg, 1971). Under semi-synthetic diets as used in these studies, some of
the enzymatic activities are either absent or require very sensitive methods of detection
(Wattenberg, 1971). We did not measure the activity of P-450 on intestinal mucosa
because it was below the detection limit of the method employed.
Lipid peroxidation
Lipid peroxidation, measured as TBARS production, was significantly higher in
the livers and the intestinal mucosa of the Fe overloaded groups (Table 16 and Appendix
G, Table 28). This is in accordance with reports of in vivo enhanced liver lipid
peroxidation due to chronic Fe overload (Britton et al., 1987). Similar results were
obtained with Fe overloaded animals induced with injected iron dextran (experiment one)
and with carbonyl iron (experiment two). Se-deficient and Fe overloaded rats (-Se++Fe),
when compared with Se supplemented and Fe overloaded animals (+Se++Fe), had
significantly higher TBARS production in liver and intestinal mucosa. This probably
reflects the drastic reduction in GSHPx activity reached after three months of dietary Se
deficiency. Similar results were observed in experiment two in Fe overloaded rats fed a
similar carbonyl iron diet for two months. Animals fed the marginal Fe content diet did
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not show a higher susceptibility to lipid peroxidation (Table 16 and Appendix G, Table
28). However, Fe deficiency could favor the induction of lipid peroxidation in liver and
other organs. Fe deficiency can affect the metabolism of lipids and can also modify the
enzymatic activity of important lines of cellular defense against lipid peroxidation. It has
been reported that Fe deficiency may induce hypertriglyceridemia and fatty livers in pups
of Fe-deficient rats and Fe supplementation reverses the lipid accumulation (Bartholmey
and Sherman, 1985). A feasible explanation relies in the requirements of Fe for the
synthesis of carnitine, an essencial cofactor for oxidation of normal fatty acids
(Bartholmey and Sherman, 1985). Iron has also an integral role in the production of
unsaturated fatty acids; because in rats fed an Fe-deficient diet, the ratio monounsaturated
to saturated fatty acids in tissue lipids is reduced. This seems to be a consequence of a
reduction in the activity of a desaturase Fe-containing enzyme complex found in several
tissues (Larkin et al., 1986). Iron deficiency can also lower the enzymatic activity of
GSHPx and catalase (Rodvien et al., 1974; MacDougall, 1972) and reduce the normal
cellular defense against lipid peroxidation. Bromotrichloromethane did not enhance lipid
peroxidation among the four dietary treatment groups evaluated (Table 17 and Appendix
G, Table 29). At the marginal level of Fe intake, no significant susceptibility to induced
lipid peroxidation by the halomethane was observed as compared with that of controls; a
more drastic Fe deficiency or greater exposure to the halomethane may be required to
induce such a response.
The lowered Se-dependent GSHPx activity alone or in combination with Fe
deficiency, did not favor the induction of lipid peroxidation by the gavaged CBrCI3.
Anemia has been the main public health concern associated with Fe deficiency. However,
long before anemia can take place, a lowered level of Fe can be noticed in the body Fe
reserves measured as serum ferritin (Mertz, 1981).

This initial Fe deficiency is

accompanied by lowered activities of many important enzymes as commented before. This
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Table 17--Glutathione peroxidase (GSHPx) and cytochrome P-450 activity and TBARS
production in rats fed a diet deficient in selenium and/or iron and gavaged with
bromotrichloromethane.
Dietary treatments
Measures

+Se+Fe

-Se+Fe

+Se-Fe

-Se-Fe

GSHPx, J.!M NADP/min/mg protein
Liver
f1 (180)
f2 (0.1)
f3 (1.6)

0.73 ±0.10a 0.07 ±0.01b
0.83 ±0.04 0.08 ±0.01

0.78 ±0.06a
0.70 ±0.08

0.09 ±0.01b
0.08 ±0.01

Control
Dose

Intestinal tract
f1 (13)
f2 (4.2)
f3 (0.96)

0.15 ±0.02a 0.05 ±0.01b
0.08 ±0.01 0.04 ±0.00

0.17 ±0.06a
0.13 ±0.05

0.05 ±0.01b
0.05 ±0.01

Control
Dose

1.32 ±0.29a
1.37 ±0.25

1.57 ±0.30a
1.31 ±0.19

1.65 ±0.20a
1.38 ±0.18

Control
Dose

1.69 ±0.13a
1.62 ±0.35

1.78 ±0.28a
1.71 ±0.26

1.83 ±0.08a
1.74 ±0.11

Control
Dose

13 ±2a
16 ±4

11 ±4a
13 ±2

10 ±3a
13 ±5

Control
Dose

69 ±21a
102 ±55

60 ±15a
125 ±32

57 ±25a
74±29

Control
Dose

P-450, Jlg Para-nitrophenol/hr/mg protein
Liver
Substrate: para-nitroanisol
f1 (0.34)
1.47 ±0.30a
f2 (1.30)
1.41 ±0.34
f3 (0.40)
Substrate: EPNb
f1 (0.31)
1.79 ±0.20a
f2 (1.07)
1.59 ±0.24
f3 (0.10)
TBARS, nM/100 mg protein
Liver
f1 (0.42)
f2 (1.07)

12±3a
13 ±4

f3 (0.12)
Intestinal mucosa
f1 (0.93)
65 ±21a
f2 (3.93)
65 ±13
f3 (0.91)

aCBrC13 (9.9 mM/ml). Dose: 5J.!l/kg. Data are means ±standard deviation for each
treatment group; n = 5 rats in all groups. Table f values (alpha = 0.05). Diet: f1 (3, 16) =
3.24. Dose: f2 (1,16) = 4.49. Interaction: f3 (3,16) = 3.24. If any calculated f is
higher than the respective table f value, there is a significant difference between the
compared factors. Values in the same row with the same superscript letter are not
significantly different based on orthogonal comparisons. See Appendix G, Table 29.
bEPN: 0-ethyl-0-(4-nitrophenyl) phenylphosphonothioate.
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is particularly noticeable in tissues with a fast cell turnover rate such as in the intestinal
mucosa (Pascoe et al., 1983). However, the exact impact in human health of those altered
enzymatic activities is not known.
Since not enough Fe overloaded animals survived the three months of treatment,
CBrCl3 was not tested in the Fe overloaded groups. However, in accordance with the
results discussed in experiments one and two, the combination of Fe overload and Se
deficiency might have rendered these animals more susceptible to lipid peroxidation
stressors like CBrCl3.
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CHAPTER V
SUMMARY

Dietary Se-deficiency alone or in combination with Fe overload or marginal
dietary Fe intake was induced in rats. Two models of experimental Fe overload induction
were used: oral ingestion of carbonyl iron, which causes hepatic Fe distribution in a
pattern analogous to that seen in human hepatocytes due to hereditary hemochromatosis;
and intramuscular injections of iron dextran, which causes a more homogeneous
deposition of Fe in hepatocytes and Kupffer cells. Both injected iron dextran and oral
carbonyl iron are used in therapy for Fe-deficiency anemia. The induced Fe overload was
reflected by a higher Fe levels in the liver and intestines of the treated animals. Higher in
vivo lipid peroxidation, measured as TBARS, was observed in both tissues from the Fe

overloaded rats. Lipid peroxidation was even higher in animals with Fe overload and Sedeficiency chronically induced over periods of two and three months as compared with
animals with acute Fe overload and Se deficiency induced over a period of 20 days.
Chronically induced Fe overload was required for the reduction of the Se-dependent
GSHPx activity in the liver, in agreement with previous reports. The first observation of
this phenomenon in the intestinal mucosa of those animals is reported here. Under acute
Fe overload no change in the Se-dependent GSHPx activity was observed in liver or
intestinal mucosa.

This suggests the possiblility that patients with hereditary

hemochromatosis, who have a similar liver Fe distribution than that due to chronic Fe
overload, may also experience a lowered GSHPx activity which would increase their
susceptibility to lipid peroxidation even more than would be anticipated from their
increased tissue Fe levels alone. More research is required to elucidate further this
possibility along with the potential need for increased Se intake to counteract such an
effect. Low doses of CBrCl3 elevated the TBARS production in the intestinal mucosa of
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theSe-deficient and Fe overloaded animals, the group of animals most susceptible to lipid
peroxidation. The first in vivo observation of the extrahepatic action of this compound is
reported here; this in agreement with previous in vitro evidence of its action in intestinal
tissue. The possibility of an increased susceptibility to lipid peroxidation initiators in the
environment among people with abnormally high levels of tissue Fe should be
contemplated and a strategy for its evaluation and prevention should be developed. The
marginal Fe deficiency induced did not affect Se-dependent GSHPx activity or CBrCl3
induced lipid peroxidation. It is possible that a more drastic Fe-deficiency might affect
GSHPx activity and should be considered in further studies.
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APPENDIX A
SPECfROPHOTOMETRIC DETERMINATION OF IRON WITH FERROZINE
REAGENT
(Stookey, 1970)
Clean glassware
A. Soak glassware overnight in 6 N hydrochloric acid.
B. Soak glassware overnight in 25 mM EDTA, tetrasodium salt (optional).
C. Rinse 12 times with deionised water.

D. Dry thoroughly.
Reagents
A.

0.02 % ascorbic acid in 0.2 N hydrochloric acid (to reduce ferric iron to ferrous
iron).
1) In a 100 ml volumetric flask dissolve 0.02 g ascorbic acid (Baker, reagent grade)
in a small quantity of deionised water.
2) Add 1.67 ml concentrated hydrochloric acid and dilute to volume.
3) Make fresh every day and store at 4 C.

B. 10% ammonium acetate buffer.
Dissolve 10 g ammonium acetate (Baker analyzed) in 100 ml deionised water of final
volume.
C.

1 mM ferrozine reagent (3-(2-Pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4,-triazine)
In a volumetric flask dissolve 0.051 g ferrozine in 100

ml deionised water. Keep it

in the dark and refrigerate.
Iron standard
A. Dissolve 100.0 mg electrolytic iron in concentrated hydrochloric acid and dilute to 1
liter with deionised water. Make serial dilutions of this stock solution to prepare a
calibration curve.
B. Prepare a blank with deionised water instead of sample or standard.
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C. Use blank to set absorbance to zero.

D. Plot standard curve: A 562 vs

~g

Fe.

Typically, a sample which has a total of 5 ~g Fe (i.e. 5 ~g/5 ml) has an absorbance of
0.5; 10 ~g Fe has an absorbance of 1.0; etc.
Sample digestion
A.

Weigh 1 g sample of diet; or pipette a 1 ml sample of homogenate into a 50 ml
Erlenmeyer flask.

B.

Add a pyrex glass bead, and 20 ml nitric acid. Heat to dryness and add 5 ml
hydrogen peroxide. Heat it again to dryness. Dilute appropriately with hydrochloric
acid and take the 0.5 aliquot required for the iron analysis.

Procedure
A. Add 0.5 ml of digested sample solution.
B. Add 0.38-0.50 ml 12 N sodium hydroxide
C. Check acidity with pH paper on one of the triplicates. This assay must be conducted
at a nearly neutral pH (6-7).
D. Add 1.35 ml ascorbate solution. Mix and let stand for 15 min.
E. Add 1.00 ml acetate buffer solution. Mix well.
F. Add 1.35 ml Ferrozine reagent. Mix well.
G. Make up volume to 5 ml with deionised water.
H. Wait 30 min. Vortex the tubes and read absorbance at 562 nm.
(Best results are obtained in samples containing 1-50 ~g Fe).
Principle
Organic molecules containing the atomic configuration
HH
-N=C-C=Nreact as bidentate ligands with ferrous ion to give colored complex species. Ferrozine
reacts with divalent iron to form a stable magenta complex species soluble in water.
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APPENDIXB
GLUTATIIIONE PEROXIDASE ACITVITY DETERMINATION
(Paglia and Valentine, 1967)
Reagents
A. 0.05 M potassium phosphate buffer pH 7.
Mix equal volumes of monobasic potassium phosphate (6.8 g in 500 ml deionised
water) and dibasic potassium phosphate (8.71 gin 500 ml deionised water) containing
5 mM EDTA (1.46 grin 1liter buffer). Total1liter. Check pH.
B. 8.4 mM B-Nicotinamide adenine dinucleotide phosphate, reduced form (NADPH).
In a 10 ml volumetric flask, dissolve approximately 79.2 mg NADPH in 10 ml
deionised water. Before weighing the NADPH correct for atomic weight of sodium,
23, and atomic weight of hydrogen, 1. Similarly, adjust the molecular weight (m.w.)
of water of hydration. Adjust for purity: m.w. divided by the % purity. When
preparing small quantities, the concentration per ml desired, C, should be multiplied
by the number of milliliters of reagent required and an exact weighing made of
approximately this quantity. The volume of water to be added V, is then obtained by
dividing the exact quantity that has been weighed, W by the concentration per
milliliter desired: V=W/C.
C. Glutathione reductase (GSSG-R).
Yeast crystalline, 100 e.u. per mg protein in 1 ml. Calbiochem, Los Angeles, CA.
D. 1.125 M sodium azide.
Dissolve 7.31 g sodium azide in 100 ml deionised water.
E. 0.15 M reduced glutathione (GSH). In a 10 ml volumetric flask, dissolve 0.461 g
GSH in 10 ml deionised water.
F. 2.2 mM hydrogen peroxide.
Dilute 5 ml 30 % hydrogen peroxide to 50 ml with deionised water. Take exactly 5 ml
of the diluted hydrogen peroxide and dilute it to 2000 ml.
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Sample
LIVER: Dilute 0.1 mlliver supernatant (from homogenate centrifuged at 10.000 g, as
described in chapter ill) in 5 m1 buffer.
G.I. MUCOSA: Dilute 0.1 ml gastrointestinal mucosa supernatant (from homogenate
centifugued at 10.000 g, as described in chapter ill) in 0.2 m1 buffer.
Procedure

A. In a 10 m1 disposable culture tube, place 2.8 m1 of reaction mixture (2.58 m1 buffer,
0.1 m1 NADPH, 0.01 m1 GSSG-R, 0.01 m1 sodium azide, and 0.1 m1 GSH)
B. Add 0.1 m1 sample.
Let it equilibrate at 20 C for 5 min.
C. Add 0.1 m1 substrate (To initiate the reaction).
D. Read absorbance at 340 nm. The conversion of NADPH to NADP is followed
spectrophotometrically by continuous recording of the change in absorbance of the
system at 340 nm between 2 and 4 minutes after initiation of the reaction, employing a
cuvette with a 1 em light path.
E. Enzyme units were defined as the number of micromoles of NADPH oxidized per
minute per mg protein; and were calculated on the basis of a molar absorptivity for
NADPH at 340 mu of 6.22 x 10-6. Protein content of the samples was determined by
Bradford's method (Bradford,1976) using bovine serum albumin as standard.
F. Control. Human blood hemolysate (1 m1 whole blood, 5 m1 saline, 6 ml Drabkins's
reagent, and 16 ml deionised water) was prepared, and 0.1 m1 hemolysate instead of
sample was added to the reaction mixture as a control. Human blood GSHPx activity
is 30.82 + 4.65 IU/g Hb (Beutler, 1984). Hemoglobin content in whole blood was
determined spectrophotometrically as cyanmethemoglobin (Crosby et al., 1954).
Reactions
GSHPx
GSSG-R
2 GSH + H202 --------- H20 + GSSG --------- 2 GSH
NADPH
NADP
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APPENDIXC
LIPID PEROXIDATION: DETERMINATION OF TIIIOBARTURIC ACID
REACTIVE SUBSTANCES (TBARS)
(Buege and Aust, 1984)
Reagents
A. Stock TCA-TBA-HCl reagent.
1) Add 15 g (15 % w/v) trichloroacetic acid (TCA) to a 100 ml volumetric that
contains approximately 50 ml deionised water.
Add 0.375 g (0.375 % w/v) thiobarbituric acid, (4,6-Dihydroxy-2

2)

-thiopyrimidine), TBA.
3) Add 2.059 ml 0.25 N hydrochloric acid (HCl). Take it to volume. It may be
mildly heated to assist · in the dissolution of TBA.
B. Tris potassium chloride buffer (150/25 mM); pH 7.5
1) Mix 11.17 5 g potassium chloride in a 1000 ml volumetric flask with some
distilled water. 2) Add 3.028 g tris (Hydroxymethyl) aminomethane and make it
to volume. Adjust pH.
Procedure
A. Place 440 Jll Tris potassium chloride buffer in a 10 ml

disposable culture tube.

B. Add 60 Jll1% butylated hydroxytoluene (BHT) . Prepared

as 0.1 g BHT in 10 ml

ethanol.
C. Add 60 Jll sample (supernatant from homogenate centrifuged at 10.000 g as described

in chapter III).
D. Blank: Substitute sample with buffer.
E. Add 1500 Jll stock reagent.
F. Mix thoroughly.
G. Incubate 15 min in a boiling water bath.
H. Cool under running water.
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I. Centrifuge at 2000 g for 10 min.

J. Blank: Substitute sample with buffer.
K. Read in a spectrophotometer at 535 nm. The absorbance of the sample is determined

at 535 nm against a blank that contains all the reagents minus the sample. The
malondialdehyde concentration of the sample can be calculated using an extinction
coefficient of 1.56 x 105 M-1 cm-1. Units are expressed as nM TBARS/100

mg

protein. Protein content of the samples was determined by the Bradford method,
using bovine serum albumin as standard (Bradford, 1976).
L.

To determine potential TBARS formation during sample storage, four supernatent
samples (S 12) were analyzed after 1 and 8 days of storage, four different
supernatent samples (S 12) were analyzed after 1 day and 1 month of storage, and
four additional supernatent samples (S12) were analyzed after 1 day and 2 months of
storage. The data were analyzed by the t-dependent statistical test. Samples analyzed
after 1 day and 8 days of storage averaged 448 ±174 and 437 ±125 nM TBARS/ml
cytosol (t-dep=0.10, NS), respectively. Samples analyzed after 1 day and 1 month
of storage averaged 178 ±178 and 174 ±180 nM TBARS/ml cytosol (t-dep=.01,
NS), respectively. And, samples analyzed after 1 day and 1 month of storage
averaged 207 ±235 and 194 ±220 nM TBARS/ml cytosol (t-dep=.08, NS),
respectively. It was concluded that storage time did not increase supernatent TBARS
levels in this procedure.

Principle
Malondialdehyde, formed from the breakdown of polyunsaturated fatty acids, serves
as a convenient index for determining the extent of the peroxidation reaction. It has
been identified as the product of lipid peroxidation that reacts with thiobarbituric acid
to give a red species with an absorbance at 535 nm.
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APPENDIXD
DETERMINATIN OF CYTOCHROME P-450 ACTIVITY
(Kinoshita et al., 1966)
Reagents
A. 0.1 M phosphate buffer pH 7 .8.
1)

In a 100 ml volumetric flask dissolve 1.42 g of dibasic anhydrous sodium
phosphate with deionised water.

2)

Adjust to pH 7.8 with concentrated hydrogen chloride.

B. Cofactor solution.
1) B-Nicotinamide adenine dinucleotidphosphate (NADP).

Dissolve 100 mg

NADP in 10 ml deionised water.
2) Glucose 6-phosphate. Dissolve 100 mg glucose 6-phosphate in 10 ml deionised
water.
3) Mix 1) and 2) in equal amounts.
C. Substrates
1) Stock solution.

Prepare a 20 % ethanol and 80 % propylene glycol

(propanediol) solution.
2) 0-ethyl, 0-(4-nitrophenyl) phenylphosphonothioate; (EPN) solution. Dissolve 7
mg EPN in 1 ml stock solution.

Immediately before the initiation of the

experiment, mix one part of EPN solution to 9 parts phosphate buffer.
3)

para-nitroanisol solution. Dissolve 14 mg para-nitroanisol in 1 ml stock solution
Immediately before the initiation of the experiment mix one part of para-nitroanisol
solution to 9 parts phosphate buffer.

D. Enzyme preparation. Use 0.1 mlliver homogenate.
E. 0.5 M Glycine buffer.
1)

Dissolve 0.375 g glycine in 10 ml deionised water.

2)

Adjust to pH 9.5 with sodium hydroxide.
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F. Standard curve (for both substrates)
1)

In a 10 ml volumetric flask dissolve 4.2 mg para-nitrophenol in deionised water.
Take 1 ml of this solution and dilute it to 5 ml in a volumetric flask.

3)

Place 25 1.1.1, 50 1.1.1, 75 1.1.1 and 100 1.1.1 of the above solution in 10 ml disposable
culture tubes. Take each tube to a volume of 1 ml with deionised water.

4)

Add 2.5 ml acetone and 0.2 ml glycine buffer.

5)

Read in a spectrophotometer at 410 nm.

Enzyme assay
1)

Add 0.5 ml buffer to a 10 ml disposable culture tube.

2)

Add 0.2 ml of cofactor solution.

3)

Add 0.2 ml substrate EPN solution or substrate para-nitroanisol solution.

4)

Add 0.1 ml homogenate.

5)

Incubate 30 min in a shaker at 37.5 C.

6) Add 2.5 ml acetone.
7)

Add 0.2 ml glycine buffer.

8) Mix well.
9) Centrifuge at 3000 rpm for 10 min.
10) Read at 410 nm.
11) For both substrates, the enzyme activity is expressed as micrograms of p-

nitrophenol formed from the substrate/hr/mg protein. Protein was determined by
the Bradford method, using bovine serum albumin as standard (Bradford,
1976).
Principle
The hepatic cytochrome P-450 system of enzymes present in the liver homogenate,
catalizes the oxidation of EPN and the 0-dealkylation of para-nitroanisole,
metabolizing these substrates into para-nitrophenol; which is measured in each case
as l.l.g para-nitrophenol produced /mg protein (homogenate)/h.
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APPENDIXE
CYANME'IHEMOGLOBIN METIIOD FOR DETERMINING BLOOD HEMOGLOBIN
(Crosby et al., 1954)
Drabkin's Reagent Preparation
One gram sodium bicarbonate, 52 mg potassium cyanide, and 198 mg potassium
ferricyanide were dissolved and diluted to 1000 rnl in a volumetric flask with distilled
water. The solution was stored in a dark brown glass container at room temperature.
Procedure
1)

Twenty microliters of unclotted blood was pipetted into 5 ml Drabkin's reagent.

2)

The solution was mixed well and allowed to set 30 min. Absorbance was read at
540 nm in a spectophotometer.

3)

Hemoglobin concentrations were determined from the standard curve derived
from commercial hemoglobin standards (Fischer Scientific Company,
Diagnostics

Division, Orangeburg, New York.)
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APPENDIXF
PROTEIN DETERMINATION IN TISSUE HOMOOENATES
(Bradford, 197 6)
Rea~ents

A . Protein Reagent. Dissolve 100 mg of coomassie brilliant blue G-250 in 50 ml of 95
%ethanol. Dissolve with continuous stirring for 2-3 hr. To this solution add 100 ml
of 85 % phosphoric acid. Dilute to one liter and shake or stir for 1 hr. Before use,
filter it with double layered #1 filter paper.
B . Buffer, 0.1 M phosphate buffer, pH 7 .8. Add 1.42 gr anhydrous dibasic sodium
phosphate to 100 ml deionised water. Mix. Adjust to pH 7.8 with concentrated
hydrochloric acid.
C. Protein standard. In a volumetric flask, dissolve 10 mg of bovine serum albumin

(BSA) in 10 ml buffer. Pipette 15, 25, 50 and 75
disposable culture tubes. Adjust to 100

~1

~1

dissolved BSA in 10 ml

with buffer. Proceed with the steps for the

protein assay described below. Measure the absorbance at 595 nm against the reagent
blank (zero BSA). Plot

~g

protein against absorbance to generate a standard curve

for use in determining protein in unknown samples.
Sample dilution
A. Liver homogenate. Take 50 ~1 homogenate (prepared as described in chapter ill) and
dilute with 5 ml buffer.
B . Intestinal homogenates. Take 50

~I

of intestinal mucosa homogenate (prepared as

described in chapter III) and dilute with 1 ml buffer. The same procedure was used
for the dilution of whole intestine homogenate.
C . Liver supernatant. Take

25~1

of liver supernatant (prepared as described in chapter

III) and add 2.5 ml buffer.
D . Gastrointestinal mucosa supernatant. Take 100
add 2.0 ml buffer.

~I

intestinal mucosa supernatant and
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Protein assay
Pipette 100 J.. Ll sample in 10 ml disposable culture tubes. Add 5.0 ml of filtered
protein reagent to each tube. After 2 minutes and before an hour, vortex the test tube
and read the absorbance against the reagent blank at 595 nm.
Principle
The method involves the binding of coomassie brilliant blue G-250 to protein. The
binding of the dye to protein causes a shift in the absorption maximum of the dye
from 465 to 595 nm, and it is the increase in absorption at 595 nm which is
monitored. This assay is very reproducible and rapid with the dye binding process
virtually complete in approximately 2 min with good color stability for 1 h.
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APPENDIXG
TABLES OF ORTHOGONAL COMPARISONS
Table 18--0rthogonal comparisons as tests of significance for weight, hemoglobin, and
serum iron (Table 3)
Calculated f
Comparison

Body Weight

Hemoglobin

0.00

0.02

0.00

+Se+Fe vs +Se++Fe

24.74

0.24

66.60

+Se+Fe vs -Se++Fe

15.54

0.24

84.48

-Se+Fe vs +Se++Fe

24.56

0.12

66.25

-Se+Fe vs -Se++Fe

15.41

0.40

84.09

1.06

0.96

1.06

(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

39.60

0.01

150.18

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

0.51

0.35

0 .55

Control vs dose II

0.19

0.07

0.21

Control vs dose I

0.74

0.70

0 .19

Dose II vs dose I

1.68

1.22

0.00

451.77

7.00

2. 12

+Se+Fe vs -Se+Fe

+Se++Fe vs -Se++Fe

Serum iron

aError line entries are MSE.
Table f values:
Diet f1 (1,48) = 4.0
Dose f2 (1 ,48) = 4.0
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.

89

Table 19--0rthogonal comparisons as tests of significance for total iron in intestinal
mucosa, whole intestine, and liver (Table 4)
Calculated f
Intestinal
mucosa

Whole
intestine

Liver

1.57

0.05

0.00

+Se+Fe vs +Se++Fe

20.92

101.85

273.45

+Se+Fe vs -Se++Fe

26.47

105.38

289.52

-Se+Fe vs +Se++Fe

33.97

106.38

272.32

-Se+Fe vs -Se++Fe

40.96

109.98

288 .36

+Se++Fe vs -Se++Fe

0.33

0.03

0.23

(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

60.20

211.76

561.71

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

0.23

0.00

0.13

Control vs dose II

0.13

0.09

0.26

Control vs dose I

0.00

0.57

0.57

Dose II vs dose I

0.18

0.21

0.06

Comparison
+Se+Fe vs -Se+Fe

------------------------------------------------------------------------------------------------------Errora

0.97

13.38

25 .35

aError line entries are MSE.
Table f values:
Diet f1 (1,48) = 4.0
Dose f2 (1 ,48) = 4.0
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 20--0rthogonal comparisons as tests of significance for glutathione peroxidase
(GSHPx) and cytochrome P-450 activity and for TBARS production in the liver (Table 5)
Calculated f
Comparison

GSHPx

P-450
EPN

+Se+Fe vs -Se+Fe

TBARS

para-nitroan

144.54

0.05

2.45

0.05

+Se+Fe vs +Se++Fe

2.62

1.07

5.94

35 .35

+Se+Fe vs -Se++Fe

159.09

2.52

7.64

56.69

-Se+Fe vs +Se++Fe

186.11

1.57

0.76

37.98

-Se+Fe vs -Se++Fe

0.35

3.26

1.43

60.00

202.58

0.31

0.11

2.51

0.53

4.03

6.61

93 .73

344.68

0.06

1.79

0.93

Control vs dose II

1.63

0.33

0.24

0.83

Control vs dose I

0.05

0.26

1.05

0.29

Dose II vs dose I

1.10

1.18

0.29

0.14

0.01

0.07

0.04

0.05

+Se++Fe vs -Se++Fe
(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)
(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

aError line entries are MSE.
Table f values:
Diet f1 (1,48) = 4.0
Dose f2 (1,48) = 4.0
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.

81

Table 21--0rthogonal comparisons as tests of significance for glutathione peroxidase
(GSHPx) activity and TBARS production in the intestinal mucosa (Table 6)
Calculated f
TBARS

Comparison

GSHPx

+Se+Fe vs -Se+Fe

33.76

1.21

+Se+Fe vs +Se++Fe

3.19

21.28

+Se+Fe vs -Se++Fe

34.14

27.45

-Se+Fe vs +Se++Fe

57 .69

12.35

-Se+Fe vs -Se++Fe

0.00

17.14

58 .19

0.39

1.54

38.31

90.30

1.49

Control vs dose II

0.00

7.84

Control vs dose I

0.18

0.06

Dose II vs dose I

0.23

9.32

Errora

0.00

0.10

+Se++Fe vs -Se++Fe
(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)
(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

aError line entries are MSE.
Table f values:
Diet f1 (1,48) = 4.0
Dose f2 (1 ,48) = 4.0
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors .
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Table 22--0rthogonal comparisons as tests of significance for weight, hemoglobin, and
serum iron (Table 8)
Calculated f
Comparison
+Se+Fe vs -Se+Fe

Body Weight

Hemoglobin

Serum Fe

0.4

0.0

0.6

+Se+Fe vs +Se++Fe

122.1

1.7

0.2

+Se+Fe vs -Se++Fe

163.8

6.9

0.2

-Se+Fe vs +Se++Fe

135.8

2.0

0.1

-Se+Fe vs -Se++Fe

179.5

7.6

0.1

3. 1

1.8

0.0

298.9

8.2

0.0

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

0.7

0.7

0.2

(+Se+Fe & -Se++Fe)
vs
(-Se+Fe & +Se++Fe)

2.8

1.1

0.4

Control vs dose

1.9

1.5

2.3

661.4

17.4

1.4

+Se++Fe vs -Se++Fe
(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

Errora

aError line entries are MSE.
Table f value (alpha 0.05):
f (1,16) = 4.49
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 23--0rthogonal comparisons as tests of significance for iron in liver, intestinal
mucosa, and whole intestine (Table 9)
Calculated f
Comparison

Liver

Intestinal
mucosa

Whole
intestine

----------------------------------------------------------------------------------------------------------0.0

0.0

0.3

+Se+Fe vs +Se++Fe

50.1

81.1

192.9

+Se+Fe vs -Se++Fe

92.8

123.1

176.8

-Se+Fe vs +Se++Fe

50.1

77.4

209.0

-Se+Fe vs -Se++Fe

92.7

118.6

192.2

6.5

4.4

0.4

193.6

197.9

385.1

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

3.3

2.6

0.7

(+Se+Fe & -Se++Fe)
vs
(-Se+Fe & +Se++Fe)

3.2

1.8

0.0

Control vs dose

0.3

0.8

0.1

20.8

1.3

0.6

+Se+Fe vs -Se+Fe

+Se++Fevs-Se++Fe
(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

Errora

aError line entries are MSE.
Table f value (alpha 0.05):
f (1,16) = 4.49
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 24--0rthogonal comparisons as tests of significance for glutathione peroxidase
(GSHPx) and cytochrome P-450 activity and for TBARS production in the liver (Table
10).
Calculated f
Comparison

P-450

GSHPx

TBARS

--------------------------

EPN

para-nitroan

------------------------------------------------------------------------------------------------------212.4

0.2

0.0

0.0

+Se+Fe vs +Se++Fe

14.8

0.8

0.6

68.5

+Se+Fe vs -Se++Fe

232.9

1.7

1.3

150.9

-Se+Fe vs +Se++Fe

115.1

0.2

0.4

67.5

-Se+Fe vs -Se++Fe

0.5

0.7

1.0

149.5

+Se++Fe vs -Se++Fe

130.3

0.2

0.2

16.1

(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

10.3

1.5

1.6

210.1

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

337.8

0.4

0.1

8.3

(+Se+Fe & -Se++Fe)
vs
(-Se+Fe $ +Se++Fe)

5.0

0.0

0.0

7.8

Control vs dose

0.8

0.0

0.0

1.7

0.01

0.2

0.2

0.1

+Se+Fe vs -Se+Fe

aError line entries are MSE.
Table f value (alpha 0.05):
f (1,16) = 4.49
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 25--0rthogonal comparisons as tests of significance for glutathione peroxidase
(GSHPx) activity and TBARS production in the intestine (Table 11).
Calculated f
Comparison
+Se+Fe vs -Se+Fe

GSHPx

TBARS

35.1

0.1

+Se+Fe vs +Se++Fe

7.0

4.8

+Se+Fe vs -Se++Fe

58 .2

30.1

-Se+Fe vs +Se++Fe

10.7

3.3

-Se+Fe vs -Se++Fe

2.9

26.2

+Se++Fe vs -Se++Fe

24.7

10.8

(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

9.5

26.7

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

59.4

6.7

(+Se+Fe & -Se++Fe)
vs
(-Se+Fe & +Se++Fe)

0.4

4.3

Control vs dose

0.1

5.0

0.0

0.7

aError line entries are MSE.
Table f value (alpha 0.05):
f (1,16) = 4.49
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 26--0rthogonal comparisons as tests of significance for fmal body weight,
hemoglobin, and iron in intestinal mucosa, whole intestine, and liver (Table 14)
Calculated f

--------------------------------------------------------------------Iron

Comparison

Animal
Weight

-----------------------------------

Hb

Intestinal
mucosa

Whole
intestine

Liver

----------------------------------------------------------------------------------------------------------+Se+Fe vs -Se+Fe

0.01

0.00

0.14

0.02

0.02

+Se+Fe vs +Se-Fe

0.31

0.74

3.42

0.16

3.79

+Se+Fe vs -Se-Fe

0.14

2.90

0.14

0.26

3.59

+Se+Fe vs +Se++Fe

167

0.05

223

125

602

-Se+Fe vs -Se++Fe

198

0.02

141

97

536

+Se++Fe vs -Se++Fe

2.82

0.11

8.47

0.55

0.25

(+Se+Fe & -Se+Fe)
vs
(+Se++Fe & -Se++Fe)

230

0.00

226

139

716

+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

0.74

0.03

3.29

0.10

0.12

(+Se+Fe & +Se-Fe)
vs
(+Se+Fe & -Se+Fe)

0.07

0.26

0.71

0. 10

1.09

(+Se+Fe & -Se+Fe)
vs
(+Se-Fe & -Se-Fe)

0.00

2.38

4.07

0.00

4.82

438

1.80

0.37

0.54

0.81

aError line entries are MSE.
Table f value (alpha 0.05):
f (1,24) = 4.26
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 27--0rthogonal comparisons as tests of significance for hemoglobin and serum iron
in rats (Table 15).
Calculated f
Comparison

Hemoglobin

Serum Iron

+Se+Fe vs -Se+Fe

0.40

1.07

+Se+Fe vs +Se-Fe

0.29

5.92

+Se+Fe vs -Se-Fe

4.85

7.30

-Se+Fe vs +Se-Fe

1.38

1.96

-Se+Fe vs -Se-Fe

8.05

2.78

+Se-Fe vs -Se-Fe

2.77

0.07

5.70

8.40

(+Se+Fe & +Se-Fe)
vs
(-Se+Fe & -Se-Fe)

0.53

0.85

(+Se+Fe & -Se-Fe)
vs
(-Se+Fe & +Se-Fe)

2.64

0.29

Control vs dose

0.42

0.02

4.03

0.55

(+Se+Fe & -Se+Fe)
VS

(+Se-Fe & -Se-Fe)

aError line entries are MSE.
Table f value (alpha 0.05):
Treatment f1 (1,16) = 4.49
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 28--0rthogonal comparisons as tests of significance for glutathione peroxidase
(GSHPx) and TBARS production in the liver and intestinal mucsa and for liver
cytochrome P-450 activity (Table 16).
Calculated f
Intestine

Liver
GSHPx
Comparison

P-450
EPN

TBARS

GSHPx

TBARS

para-nitroan

----------------------------------------------------------------------------------------------------------+Se+Fe vs -Se+Fe

139

0.89

1.00

0.00

31.1

0.50

+Se+Fe vs +Se-Fe

0.80

0.01

0.43

0.01

1.70

0.06

+Se+Fe vs -Se-Fe

116

0.08

1.23

0.01

26.1

0.14

+Se+Fe vs +Se++Fe

23.6

0.14

1.75

45.4

17.9

19.9

-Se+Fe vs -Se++Fe

1.01

0.42

0.29

152

5.76

41.7

+Se++Fe vs -Se++Fe

73.2

4.14

8.60

37.8

16.8

6.25

(+Se+Fe & -Se+Fe)
10.6
vs
(+Se++Fe & -Se++Fe)

0.03

0.17

115

13.7

37.9

(+Se+Fe & +Se++Fe)
vs
(-Se+Fe & -Se++Fe)

131

2.75

4.77

11.4

29.7

2.23

(+Se+Fe & +Se-Fe)
vs
(+Se+Fe & -Se+Fe)

53.0

0.24

0.90

0.00

15 .6

0.07

(+Se+Fe & -Se+Fe)
vs
(+Se-Fe & -Se-Fe)

0.52

0.43

2.64

0.01

0.70

0.24

----------------------------------------------------------------------------------------------------------Errora

0.01

0.03

0.06

0.09

0.001

0.10

aError line entries are MSE.
Table f value (alpha 0.05):
f (1,24) = 4.26
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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Table 29--0rthogonal comparisons as tests of significance for glutathione peroxidase
(GSHPx) and TBARS production in the liver and intestinal mucsa and for liver
cytochrome P-450 activity (Table 17).

----------------------------------------------------------------------------------------------------------Calculated f

---------------------------------------------------------------------------Intestine

Liver

--------------------------------------------

GSHPx

TBARS

P-450

---------------------GSHPx

TBARS

-------------------

EPN para-nitroan

Comparison

----------------------------------------------------------------------------------------------------------+Se+Fe vs -Se+Fe

290

0.07

0.30

0.40

12.8

1.01

+Se+Fe vs +Se-Fe

1.03

0.13

0.00

0.08

3.10

1.80

+Se+Fe vs -Se-Fe

282

0.40

0.20

0.16

10.1

0.00

-Se+Fe vs +Se-Fe

256

0.40

0.30

0.82

28.4

0.11

-Se+Fe vs -Se-Fe

0.05

0.81

1.00

1.05

0.16

0.94

+Se-Fe vs -Se-Fe

249

0.07

0.20

0.01

24.3

1.71

(+Se+Fe & -Se+Fe)
vs
(+Se-Fe & -Se-Fe)

0.32

0.79

0.50

0.85

2.34

0.07

(+Se+Fe & +Se-Fe)
vs
(-Se+Fe & -Se-Fe)

538

0.00

0.00

0.13

36.2

0.05

(+Se+Fe & -Se-Fe)
vs
(-Se+Fe & +Se-Fe)

0.76

0.15

0.50

0.28

0.92

2.67

Control vs dose

0.07

1.07

1.30

1.07

4.25

3.93

0.01

0.10

0.15

0.00

0.002

0.21

aError line entries are MSE.
Table fvalue (alpha 0.05):
Treatment f1 (1,16) = 4.49
If any calculated f is higher than the respective table f value, there is a significant difference
between the compared factors.
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